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1 INTRODUCTION 
 
1.1 Cell Cycle 
 
Two crucial events of the eukaryotic cell cycle are the duplication of chromosomes and 
their separation from each other. These two processes usually occur in discrete,  
non-overlapping stages, or phases, of the cell cycle. DNA synthesis occurs in a period 
called S-phase and chromosomal separation takes place in a subsequent period called 
M phase. M phase includes two distinct events. (A) Nuclear division (mitosis) by 
which the duplicated chromosomes are pulled to opposite poles of the cell by  
a complex apparatus known as the mitotic spindle. (B) Cytoplasm’s division 
(cytokinesis) is a process which gives two new cells, each with its own nucleus and 
roughly equal cytoplasmatic content. The period between the one M phase and the 
initiation of the next cell cycle is called interphase. The cell cycle contains two 
additional phases: G1 phase (Gap phase) occurs before S-phase, while G2 phase occurs 
before M phase (Figure 1.1). Gap phases serve as important regulatory state of 
transition, where progression into the next cell-cycle stage is controlled by a variety of 
intracellular and extracellular signals. These signals can delay cell-cycle progression, 
for example, when DNA is damaged. The phase G1 is a particularly important 
regulatory state of transition because at that point most cells choose between again 
division and or return from the cell cycle. Completion of cell cycle requires the 
coordination of a variety of de novo biosyntheses, assemblies and movements (Hunt 
and Murray, 1993). During the cell cycle, the chromosomes must be replicated, 
condensed, segregated, and last of all decondensed. The spindle poles (centrosomes) 
have to be duplicated, separated and must migrate to opposite poles of the nucleus.  
 
Cells have evolved an intricate defence network to maintain genomic integrity by 
preventing the induction of permanent damage by endogenous and exogenous 
mutagens, such as exposure to inhibitors of DNA replication or spindle assembly or to 
agents that physically damage DNA. The term checkpoint was introduced to describe  
a mechanism that actively delays a later cell phase until an earlier event is properly 
completed. For example, when DNA replication is inhibited by hydroxyurea, the cell 
arrests in early S-phase and does not undergo mitosis. This dependence of mitosis on 
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prior completion of DNA replication is due to the action of specific gene products 
(Weinert et al., 1994). Inactivation of these genes by mutation relieves the cell of this 
dependence, and such mutants will enter mitosis with incompletely replicated DNA. 
The genes that establish dependence in the cell cycle constitute checkpoints (Murray, 
1992). 
 
 
 
Spindle checkpoint
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
M
Cell cycle 
Cytokinesis 
G1/S Checkpoint
G2/M Checkpoint 
P  /  Me  /  A  /  T
S
G1 G2 
 
 
Figure 1.1: Schematic illustration of the cell cycle. Four distinct stages can be
distinguished. Gap1 (G1)  and Gap2 (G2) phases control continuous cycle progression
via molecular checkpoints G1/S and G2/M, whereas M-phase enables chromosomes to
segregate by exact codirection of the spindle formation. During S-phase, the reduced
DNA content of the cell is resynthesised. 
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Loss of checkpoint control results in genomic instability and has been implicated in the 
transformation of normal cells into cancer cells (Elledge, 1996). There are three major 
checkpoints controlling the transition of the cell cycle at three points, G1-S, G2-M, and 
M-G1 (Fig. 1.1). The checkpoint controlling the entry into S-phase (G1-S) prevents the 
cells from replicating damaged DNA. Cells with DNA damage rapidly increase p53 
protein levels by a posttranscriptional mechanism (Kuerbitz et al., 1992). Induction of 
p53 results in transcriptional activation of p53-dependent genes such as GADD45 
(Kastan et al., 1992), MDM2 (Chen et al., 1994). As a direct consequence, the cells 
either arrest in G1 or undergo apoptosis. Unlike wild-type cells, cells defective for p53 
proceed to enter the S-phase after irradiation with an increased potential for genomic 
instability (Livingston et al., 1992). The G2-M transition is prevented by DNA damage 
and by incompletely replicated DNA. A single double-strand break in the DNA will 
activate this checkpoint and prevent the cell from undergoing mitosis (Fig. 1.1) 
(Sandell and Zakian, 1993).  
Centrosome duplication occurs during the G2-phase. A defect of centrosome 
duplication stops the completion of mitosis on the G2-M checkpoint control. Germ line 
mutations of the Brca1 tumour suppressor gene predisposes women to breast and 
ovarian cancers. Cytological analysis of mouse embryonic fibroblast cells (MEFs), 
which carry a targeted mutation in the BRCA1 gene, reveals that the mutant MEFs have 
an intact G1-S checkpoint but a defect in G2-M checkpoint. About 25% of mutant cells 
also exhibit hyperamplification of functional centrosomes, leading to the formation of 
multiple spindle poles within a single cell. These abnormalities directly result in the 
unequal segregation of chromosomes, abnormal nuclear division and aneuploidy  
(Xu et al., 1999). 
One important checkpoint in M-G1 transition is the spindle checkpoint. The spindle 
checkpoint acts in monitoring the assembly of the mitotic spindle and the bipolar 
attachment of chromosomes to spindle. If microtubule defects are apparent, a signal is 
generated that leads to a delay of cell cycle progression (Hardwick 1998). Therefore, 
the spindle checkpoint can detect a multitude of spindle defects, ranging from massive 
spindle disruption induced by anti-microtubule drugs to the presence of a single 
unattached kinetochore (Rudner and Murray, 1996). Several proteins have been 
identified to be components of the spindle checkpoint (e.g. MAD1, MAD2, Bub1 and 
Bub3 in mammalian cells). These proteins are associated transiently with the 
kinetochores during mitosis (Chen et al., 1998, Taylor et al., 1998). Cells with 
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mutations in the genes encoding these proteins, are unable to arrest in mitosis in 
response to drug-induced spindle disruption. The absence of this checkpoint allows 
mouse Mad2-deficient cells to proceed even when unattached chromosomes are 
present. This leads to missegregated chromosomes and results in aneuploidy (Dobles  
et al., 2000). 
The connections between checkpoints, aneuploidy and cancer have several intriguing 
factors. In addition to the observations that the vast majority of tumour cells are 
aneuploid (Kinzler and Vogelstein, 1996), it has recently been shown that cells from 
human colorectal cancers have a continuous high rate of chromosome loss or gain 
(giving rise to a chromosome instability CIN) (Lengauer et al., 1997). It has also been 
shown, that some human lung and colorectal cancers harbour mutations in the spindle 
assembly checkpoint genes BUB1 and MAD1 (Cahill et al., 1998; Nomoto et al., 1999). 
Checkpoint lesions can increase the rate of chromosomal missegregation and have the 
potential to act as mutations that cause the loss of wild-type tumour suppressor alleles 
and thereby unravel recessive mutations. 
 
1.2 The centrosome 
 
The centrosome is positioned in the centre of interphase cells at the focus of the radial 
array of microtubules. Microtubules are polymers composed of α- and β-tubulin 
subunits, and their synthesis is initiated in the peripheral region of the centrosome by  
a complex containing the related protein γ-tubulin (Zheng et al., 1995; Moritz et al., 
1995). At the centrosome core a pair of specialized barrel shaped microtubule 
assemblies, called centrioles, are located. The centrioles and their surrounding 
pericentrolar matrix define the centrosome as one of the most complex organelles in 
the cell. The well-characterized function of the centrosomes is to nucleate and organize 
polarized microtubule arrays that generate cell polarity and to form the structural 
framework of the meiotic and mitotic spindle. 
 
Yeast cells do not contain centrioles, but exhibit morphologically similar structures 
called spindle pole bodies. Animal cells lacking centrioles do not form centrosomes 
(Bobinnec et al., 1998), but can form a bipolar spindle. This alternative spindle 
assembly pathway is also observed during meiosis of female germ cells (Szollosi et al., 
1972). Mouse oocytes and early embryos lack centrioles. In these cells, γ- tubulin is 
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located at the spindle pole of meiosis II and at mitotic poles in early cleavage stages 
(Gueth-Hollonet et al., 1993). Centriole-nucleated centrosomes have been found to 
play a role in regulating cell-cycle progression. Cells from which centrioles have been 
removed, either by microsurgery or laser ablation, progress through mitosis but arrest 
in G1 of the following cell cycle and never reach S-phase (Hinchcliffe et al., 2001; 
Khodjakov and Rieder, 2001). The generation of the zygotic centrosome is an 
intriguing but poorly understood event (Schatten, 1994). In the vast majority of animal 
species, the centrosome is paternally inherited as the so called sperm basal body. 
Fertilization leads to conversion of the basal body into a structure fully competent to 
organize the bipolar spindle of the first embryonic division. Rare exceptions do exist, 
for instance during mouse development, where centrioles arise de novo after the first 
few cell divisions (Schatten et al., 1986; 1991).  
During mitosis, the centrosomes function as spindle poles, thereby directing the 
formation of bipolar mitotic spindles and determining the cleavage furrow plane, which 
are essential for accurate chromosome transmission to daughter cells. Since each 
daughter cell receives  only one centrosome during cytokinesis, it must duplicate prior 
to the next mitosis, and do so only once. Thus, centrosome duplication must occur in 
coordination with other cell cycle events, including DNA synthesis. Indeed, duplication 
of centriols begins close to the G1/S boundary and centrosome duplication is completed 
in G2 (Vandre and Borisy, 1989; Tournier and Bornens, 1994). Abrogation of the 
regulation that coordinates centrosome and DNA duplication will likely increase the 
frequency of centrosome hyperamplification (Brinkley and Goepfert, 1998), which 
leads to formation of multipolar spindles and unequal segregation of chromosomes to 
daughter cells (Fukasawa et al., 1996). Recent studies have shown that centrosome 
hyperamplification is a common phenomena, and is a major factor contributing to 
chromosome instability in human cancer (Pihan et al., 1998; Lingle et al., 1998; Carroll 
et al., 1999).  
 
1.3 The Pelota Gene 
 
The pelota  gene locus was originally identified in a mutagenesis screen of male 
Drosophila (Castrillon et al., 1993). In homozygous mutant males, the mitotic division 
occurs normal during spermatogenesis, but the cell cycle of the meiotic division arrests 
very early in the first meiotic division. Drosophila spermatogenesis begins with the 
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generation of spermatogonia from stem cells at the tip of the testis. Each 
spermatogonium, encased within a cyst of two somatic cells, undergoes four rounds of 
mitotic division to generate 16 spermatocytes. After a premeiotic G2 phase lasting more 
than 2 days, two rounds of meiotic division yield a cyst of 64 haploid spermatids. 
Spermiogenesis, the differentiation of the spermatid, involves development of 
specialized head and tail structures, followed by sperm individualization. In males 
homozygous for pelota, the cell cycle arrests either just before or very early in the first 
meiotic cell division. The apical regions of a testis from a pelota mutant appear normal, 
filled with progressing growth phase cysts. The caudal part of the testis, which usually 
contains 64-cell spermatid cysts, is instead filled with 16-cell cysts, while meiotic 
divisions do not occur in pelota deficient spermatocytes, other aspects of 
spermatogenesis continue, resulting in 4N spermatids.  
Further studies investigating the arrest point in meiotic division revealed that the 
chromosomes in pelota mutant spermatocytes are partially condensed, but never move 
from the nuclear periphery, the nuclear envelope does not break down and the 
centrosomes separate but do not complete their migration. A spindle apparatus is never 
observed in the pelota mutant spermatocytes. These results indicate that the germ line 
cell cycle is arrested during the meiotic G2/M transition phase in pelota male 
homozygotes (Eberhart and Wasserman, 1995). Beside the effect of the mutation 
concerning the progression of spermatogenesis, the eyes of pelota homozygotes are up 
to 30 % smaller than those of heterozygous siblings. These results indicate that pelota 
is required for Drosophila eye development. The ovaries of pelota homozygous are 
very small. The mitotic zone of ovaries appear disorganized and often contains 
degenerating cells. Later stages of oogenesis are also affected. The female mutants 
produce less than 50% eggs. These results suggest that the pelota gene is also required 
for mitotic division in the ovary. Analysis of mitotic and meiotic division in the dom34 
mutants of Saccharomyces cerevisiae, which has a mutation in the pelota orthologous 
gene, reveals that the mitotic division in dom34 mutants exhibit a G1 delay, while the 
meiotic division occurs too rapid and fewer spores are produced compared to wild type. 
The yeast mutant also fails to segregate chromosomes properly (Davis and Engebrecht, 
1998). Introduction of the wild-type pelota transgene into a dom34 mutant provides 
substantial rescue of the dom 34 growth defects (Eberhart and Wasserman, 1995).  
The pelota homolog gene has been cloned and sequenced in several species including 
archaebacteria, Arabidopsis thalania, yeast, Drosophila, C.elegans, mouse and human. 
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The encoded protein ranges between 347– 395 amino acids in length. Alignment of the 
pelota protein sequence reveals that the pelota gene is highly conserved during 
evolution. The amino acid sequence of archaebacteria, yeast, Drosophila, A. thalania, 
C. elegans and human protein are 23%, 36%, 70%, 51%, 57%, 95% identical to mouse 
pelota, respectively. All species pelota sequences contain a conserved nuclear 
localization signal and have acidic domain at the carboxyl end. The human and mouse 
pelota gene have been isolated and localized on chromosome 5q11 and chromosome 
13, respectively (Shamsadin et al., 2000; Shamsadin, unpublished results). Analysis of 
the expression of the pelota gene demonstrates that the pelota transcript is present in all 
developmental stages of Drosophila. In  human, the pelota mRNA was detected in all 
analysed tissues (spleen, brain, prostate, testis, ovary, small intestine, colon and 
leukocytes). 
 
1.4 Objectives in this work 
 
The first aim of this work was the characterisation of the expression pattern of the 
mouse pelota gene during the pre- and postnatal life and during spermatogenesis. 
Furthermore, the cellular localization of the pelota protein should be analysed.  
The second goal was the evaluation of the physiological role of the mammalian pelota 
gene. For this purpose, mutant mice should be generated carrying a targeted disruption 
of the endogenous pelota gene. Subsequently, analysis of pelota-deficient mice should 
reveal functions during embryonic and/or postnatal development, respectively. The 
phenotype of the pelota deficient mice should be analysed.   
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2. MATERIALS AND METHODS 
 
2.1 Materials 
 
2.1.1 Chemicals  
 
All chemicals which are not listed here were obtained from the company Merck, 
Darmstadt, in p.a. quality.  
 
Acrylamide      Serva, Heidelberg 
Agar       Difco, Detroit, USA 
Agarose      Gibco/BRL, Karlsruhe 
Ammonium acetate     Fluka, Neu Ulm 
Ammonium sulfate    Sigma, Deisenhofen 
Ampicillin      Sigma, Deisenhofen 
Bacto-tryptone     Difco, Detroit, USA 
Bacto-Yeast-Extract     Difco, Detroit, USA 
Bisacrylamide     Serva, Heidelberg 
Blocking powder    Boehringer, Mannheim 
Bromophenol blue     Sigma, Deisenhofen 
BSA       Biomol, Hamburg 
Choloroform      Baker, Deventer, NL 
Dextran sulfate    Amersham, Freiburg 
Diethyl pyrocarbonate (DEPC)  Sigma, Deisenhofen 
Dimethyl sulfoxid (DMSO)    Merck, Darmstadt 
Dithiothreitol      Sigma, Deisenhofen 
DNA Markers     GibcoBRL, Karlsruhe 
DNase I (RNase-free)    Amersham, Freiburg 
DNA ligase     GibcoBRL, MBI 
dNTPs (100 mM)    Boehringer, Mannheim 
Dye Terminator Mix    Applied Biosystems 
Ethanol     Baker, Deventer, NL 
Ethidium bromide    Sigma, Deisenhofen 
Materials and Methods 9
Ficoll 400     Amersham, Freiburg 
FBS      Gibco/BRL, Karlsruhe 
Formaldehyde     Gibco/BRL, Karlsruhe 
Formamide     Fluka, Neu Ulm 
Geneclean-Kit    Dianova, Hamburg 
Glycerol     Gibco/BRL, Karlsruhe 
Glycine     Biomol, Hamburg 
IPTG       Biomol, Hamburg 
Jetsorb Gel Extraction Kit/300  Genomed, Bad Oeynhausen 
Kanamycin     Sigma, Deisenhofen 
Klenow-DNA-Polymerase   Amersham, Braunschweig 
Salmon sperms DNA    Sigma, Deisenhofen 
Lambda DNA     Boehringer, Mannheim 
Levamisole     Fulka, Neu Ulm 
Methyl benzoat    Fulka, Neu Ulm 
β-Mercaptoethanol    Serva, Heidelberg 
Mineral oil     Sigma, Deisenhofen 
Multipriming Kit    Amersham, Braunschweig 
Orange G     Sigma, Deisenhofen 
JETPREP-Plasmid Midi Kit   Genomed, Bad Oeynhausen 
PBS      Gibco/BRL, Karlsruhe 
Parablast     Sigma, Deisenhofen 
Picric acid     Fulka, Neu Ulm 
Phenol      Gibco/BRL, Eggenstein 
Plasmid-Miniprep Kit   Qiagen, Hilden 
Phagen-Midiprep Kit    Qiagen, Hilden 
Proteinase K     Boehringer, Mannheim 
Protein marker    Biorad, Sigma 
Radioactive substances: 
[α32P]-dCTP, (γ32 P)-dATP   Amersham, Braunschweig 
RediprimeTM II    Amersham, Freiburg 
Restriction enzymes    Biolabs, Boehringer, BRL 
Reverse Transcriptase   Gibco/BRL, Eggenstein 
RNase A      Gibco/BRL, Eggenstein 
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RNase H     Gibco/BRL, Eggenstein 
RNase Inhibitor    Boehringer, Mannheim 
RNA length standard     Gibco/BRL, Eggenstein 
RNA Now-Kit    TRI Reagent 
SDS      Serva, Heidelberg 
Select Peptone    Gibco/BRL, Eggenstein 
Spermidin     Sigma, Deisenhofen 
T 4 -DNA-Ligase    Boehringer, Mannheim 
Taq-DNA-Polymerase    Amersham, Braunschweig 
TEMED     Serva, Heidelberg 
Triton X-100     Serva; Heidelberg 
Tris      Sigma, Deisenhofen 
t-RNA (yeast)     Boehringer, Mannheim 
Tween-20     Sigma, Deisenhofen 
X-Gal      Biomol, Hamburg 
Xylencyanol     Bio-Rad, München 
Cell culture media    Gibco/BRL, Eggenstein;  
Sigma, Deisenhofen 
 
2.1.2 Solutions and buffers 
 
Ampicillin      50 µg/ml H2O 
 
Kanamycin      50 µg/ml H2O 
 
Denaturation solution     1.5 M NaCl 
0.5 M NaOH 
 
Denhardt´s solution (50x)    1% BSA 
1% Polyvinylpyrrolidon 
1% Ficoll 400 
 
Depurization solution     0.25 M HCl 
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E-buffer (10x)      300 mM NaH2 PO4 
50 mM EDTA 
 
Elution buffer      1.5 M NaCl 
20 mM Tris-HCl (pH 7.5) 
1 mM EDTA 
 
NBT- Solution     75 mg/ml 
70% Dimethyl formamide 
 
BCIP-Solution     50 mg/ml  
70% Dimethyl formamide 
 
Bouin’s solution     15 Vol. picric acid (in dH2O) 
5 Vol. Formaldehyde 
1 Vol. Acetic acid 
 
GET-buffer      50 mM Glucose 
10 mM EDTA 
25 mM Tris-HCl (pH 8.0) 
 
Hybridization solution I    5x SSPE solution 
5x Denhardt´s solution 
0.1% SDS 
 
Hybridization solution II    5x SSC 
5x Denhardt´s solution 
10% Dextran sulfate 
0.1% SDS 
 
Kinase buffer (10x)     100 mM Tris-HCl (pH 7.4) 
100 mM MgCl2  
100 mM DTT 
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1 mM ATP 
 
Ligation buffer (10x)     600 mM Tris-HCl (pH 7.5) 
80 mM MgCl2  
100 mM DTT 
 
Solution D      4.0 M Guanidinium thiocyanat 
25.0 mM Sodium citrate (pH 7.0) 
0.5% Sarcosyl  
0.1 M β-mercaptoethanol 
 
Lysis buffer I       100 mM Tris-HCl (pH 8.0) 
       100 mM NaCl 
100 mM EDTA 
0.2 mg/ml Proteinase K 
0.5% SDS 
 
Lysis-buffer II     50 mM Tris-HCl (pH 8.0) 
5 mM EDTA 
0.5% Tween-20 
 
Neutralization solution    1.5 M NaCl 
1 M Tris-HCl (pH 7.0) 
 
PBS buffer      130 mM NaCl 
7 mM Na2 HPO4 
4 mM NaH2 HPO4  
 
PBT buffer      0.1% Tween-20 in PBS (1x) 
 
SSC (20x)      3 M NaCl 
0.3 M Na3 citrate (pH 7.0) 
 
SSPE (20x)      0.02 M EDTA 
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0.2 M NaH2 PO4   
3.6 M NaCl 
(pH 7.0) 
 
Stop-Mix I      95% Formamide 
20 mM EDTA 
0.05% Bromphenol blue 
0.05% Xylen cyanol 
 
Stop-Mix II      15% Ficoll 400 
200 mM EDTA 
0.1% Orange G 
 
TBE-buffer (5x)     445 mM Tris-HCl (pH 8.0) 
445 mM Boric acid 
10 mM EDTA 
 
TE-buffer      10 mM Tris-HCl (pH 8.0) 
1 mM EDTA 
 
Washing solution I     2x SSC  
0.1% SDS 
 
Washing solution II     0.2x SSC 
 
2.1.3 Sterilization of solutions and equipments 
 
All solutions, which are not heat sensitive, were sterilized at 121°C, 105 Pa for 60 min in an 
autoclave (Webeco, Bad Schwartau). Heat sensitive solutions were filtered through  
a disposable sterile filter (0.2 to 0.45 µm pore size). Plasticware was autoclaved as above. 
Glassware was sterilized overnight in an oven at 220°C. 
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2.1.4 Media, antibiotics and agar-plates 
 
2.1.4.1 Media for bacteria 
  
   LB Medium (pH 7.5):   1% Bacto-trypton 
0.5% Yeast extract 
0.5% NaCl 
 
LB-Agar:    1% Bacto-trypton 
0.5% Yeast extract 
0.5% NaCl 
1.5% Agar 
 
The LB medium was prepared with distilled water, autoclaved and stored at 4°C.  
 
2.1.4.2 Media for cell culture 
 
ES-cell medium: DULBECCO´s MEM (DMEM) 
 0.1 mM  Non essential amino acids 
1 mM    Sodium pyruvate 
10-6 M  ß-Mercaptoethanol 
2 mM   L-Glutamine 
20%  Fetal calf serum (FCS) 
1000 U/ml Recombinant leukaemia inhibitory factor (LIF) 
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Fibroblast cell medium (EmFi): 
DULBECCO´s MEM (DMEM) 
2 mM   L-Glutamine 
10%   FCS 
 
M2-medium:  5 ml  (10x) Hanks 
   1,25 ml (40x) HEPES 
   165 ml  (300x) Sodium pyruvate 
   0,25 ml 1M NaOH 
0,5 ml  Pencillin (6 mg/ml) / Streptomycin (5 mg/ml) 
   43 ml  H2O 
   0,2 g  BSA 
 
M16- medium: 1ml  10x Earle 
   270 µl  37,5 x NaHCO3 
   33µl  300x Sodium pyruvate 
   100µl  Pencillin (6 mg/ml) Streptomycin (5 mg/ml) 
   8,6 ml  H2O 
   40 mg  BSA 
 
For long time saving of the cells in liquid nitrogen, the following freezing media were 
used:  
 
ES cell – freezing medium:  30% ES cell medium 
50% FCS 
20% DMSO 
EmFi cells – freezing medium: 30% EmFi cell medium 
50% FCS 
20% DMSO 
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2.1.5 Antibiotics 
 
Master solutions were prepared for the antibiotics ampicillin and kanamycin, sterile filtered 
and stored at –20 °C . The antibiotic needed in each case was added after the autoclaved 
medium has cooled down to a temperature lower than  55 °C . 
 
Master solution  solve in final concentration  
Ampicillin  50 mg/ml   H2O   50 µg/ml  
Kanamycin  25 mg/ml   H2O   50 µg/ml  
G 418  40mg/ml  PBS  400 µg/ml 
 
2.1.6 IPTG / X-Gal plate 
 
LB-agar with 50 µg/ml ampicillin, 100 µM IPTG and 0.4% X-Gal was poured into  
Petri dishes. The dishes were stored at 4°C.  
 
2.1.7 Bacteria strains  
 
E. coli HB 101   Bolivar und Beckmann, 1979 
E. coli JM 109   Promega, Wisconsin, USA 
E. coli DH5α   Hanahan et al., 1985 
E. coli TOP10   Invitrogen, Leek, Niederlande 
 
2.1.8 Plasmids 
 
pBluesript SK (+/-)   Stratagene, La Jolla, USA 
pGEM-T, pGEM-T Easy Promega, Wisconsin, USA 
pPNT   Tybulewicz et al., 1991 
pUC 18   Norander et al., 1983 
pZErO-2   Invitrogen, Leek, Niederlande 
pEGFP-C1   Clontech, Heidelberg 
pASK-IBA2   Institute for Bioanalytic, Göttingen 
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2.1.9 Synthetic oligonucleotide primers 
 
The synthetic oligonucleotide primers used in this study were obtained either from 
NAPS (Göttingen, Germany) or Roth (Karlsruhe, Germany) and dissolved in water to  
a final concentration of 100 pmol/µl . 
 
F3 :   5‘  GCTGCCAACTTTGGATTCTGG  3‘ 
F11:   5‘ TGAGCCCAGACTGTACGTGAC 3‘ 
F1:   5‘ TTGCTGAGCCCAGACTGTACG 3‘ 
F7:   5‘ GAGGTCATGAAGCTCGTGAGG 3‘ 
F2:   5‘ AGGAAACGGAAAGGCAACTGC 3‘ 
F9:   5‘ GATTTGGTGGGCAGGACATG 3‘ 
R1:   5‘ TTGACCTGATTGATGTCCTGG 3‘ 
R2:   5‘ GTGGAATGCGTGGAATGTACCC 3‘ 
R6:   5‘ CTGGCTTTGCTCGCTCTTTCC 3‘ 
R9:   5‘ GCCCTAGATAAACGTCAAAGG 3‘ 
R10:   5‘ TCCCTGTGTGAGAGAACATGC 3‘ 
R5:   5‘ CCTGCTTGAGTCCATAGAACG 3‘ 
R4:   5‘ TCGATGGCCTCCACGCAAAGG 3‘ 
R7:   5‘ CCGACACATGGAGACTAGAG 3‘ 
R8:   5‘ GGCTCCTCGGGGACGAGGGTG 3‘ 
R12:   5‘ TCTGCACCTTAGCGTGAAGCC 3‘ 
PASK F:  5‘ GGGCCCGGTCTCGGGCCTCATGAAGCTCGTGAGGAAG 3‘ 
PASK R:  5‘GGGCCCGGTCTCGGCGCTAATTTGAATACATGTCCTGC 3‘ 
pECFP-C1 F: 5‘ GCGCTCGAGTGAAGCTCGTGAGGAAGAAC 3‘  
pECFP-C1 R: 5‘ CCCTCTAGAATTAATCCTCTTCAGAACTGG 3‘ 
PGK1 R:  5‘ CCATTTGTCACGTCCTGCACG 3‘ 
Poly T:  TTTTTTTTTTTTTTTTTT  
 
2.1.10 Genomic and cDNA probes 
 
EF-2 cDNA    Hanes et al.,1992 
 Human pelota cDNA   Shamsadin et al.,2001 
Materials and Methods 18
 Mouse pelota cDNA   Institute of Human Genetics, Göttingen 
 6kb pBS pelota genomic clone Institute of Human Genetics, Göttingen 
 9kb pGEM pelota genomic clone Institute of Human Genetics, Göttingen 
 
2.1.11 Eucaryotic cell lines 
 
3T3 fibroblast cells 
RI embryonic stem cells (Passage 11), Dr. A. Nagi, Toronto, Canada 
 
2.1.12 Mouse strains 
 
Mice strains C57 BL/6J and 129/Sv were ordered from Institute of Human Genetics, 
Göttingen. 
 
2.1.13 Antibodies   
 
Rabbit antiserum against γ-tubulin and FITS-conjugated goat anti-rabbit antibodies were 
purchased from Sigma (Deisenhofen) 
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2.2 Methods 
 
2.2.1 Isolation of nucleic acids 
 
2.2.1.1 Isolation of plasmid DNA 
 
2.2.1.1.1 Small-scale isolation of plasmid DNA 
 
5 ml of LB medium with the appropriate antibiotic was inoculated with a single E. coli 
colony and incubated overnight at 37°C with shaking. 1.5 ml of this culture was 
centrifuged at 5000 xg for 10 min. The pellet was resuspended in 200 µl of solution P1. 
After adding equal volumes of solutions P2 and P3, respectively, the pellet was incubated 
on ice for 15 min, and centrifuged at 13000xg at 4°C. The supernatant was transferred into 
a new tube, and 1 ml of 100% ethanol was added to precipitate the DNA. It was then stored 
at –20°C for 30 min, centrifuged at full speed for 30 min, and finally the pellet was 
dissolved in 30 µl of H2O. 
 
P1:   50 mM Tris-Cl, pH 8.0 
10 mM EDTA 
100 µg/ ml RNase A 
 
P2:   200 mM NaOH,  
1%  SDS 
 
P3:   3.0 M   potassium acetate, pH 5.5 
 
2.2.1.1.2 Large-scale isolation of plasmid DNA 
 
80 ml LB medium was inoculated with a single E. coli colony and incubated overnight at 
37°C with shaking. The culture was centrifuged at 6000 xg for 10 min. The pellet was 
resuspended in 4 ml of solution P1. In order to lyse the cells, 4 ml of solution P2 was 
added, mixed gently, and incubated for 2-3 min at room temperature. Equal amount of 
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solution P3 was added to the tube and mixed immediately by inverting. The mixture was 
centrifuged at 20000 xg for 30 min at 20°C. Meanwhile, the column that was provided by 
the kit was equilibrated with 10 ml of solution QBT. After centrifugation the lysate was 
added to the equilibrated column. The column was then washed twice with 10 ml of 
solution QC. Finally, the DNA was eluted with 5 ml of solution QF. To precipitate the 
DNA, 0.7 Vol of isopropanol was added and centrifuged at 14000 xg for 30 min at room 
temperature. The DNA was dissolved in 100 µl of H2O. 
 
QBT:   750 mM  Sodium chloride 
  50 mM MOPS pH 7,0 
  15 %   Ethanol 
   0,5 % Triton X-100 
 
QC:   1 mM   Sodium chloride 
50 mM MOPS pH 7,0 
15 %  Ethanol 
 
QF:   1,25 M Sodium chloride 
50 mM Tris/ HCl pH 8,5 
 
2.2.1.1.3 Isolation of DNA fragments after agarose gel electrophoresis 
 
For the isolation of DNA fragments of 300-4000 bp in length from agarose gels, the 
Geneclean kit from Biomol 101 (Biomol, Hamburg) was used. The principle of this 
method depends on the binding capacity of DNA to silica in high salt concentrations and 
elution in low salt solutions. After separation of DNA on an agarose gel, the DNA 
fragment to be isolated was excised with a razor blade and weighed. 3 Vol of JETSORB 
suspension was added to the tube, and the agarose slice was melted at 55°C. Depending on 
the DNA amount, required amount of GLASSMILK, which is an aqueous suspension of 
silica matrix, was added and the tube was placed on ice for 30 min. After centrifuging it at 
full speed for 2 min, the pellet was washed 2 times with „New Wash“, and allowed to dry 
at room temperature. To elute the DNA, the pellet was resuspended in 30 µl of H2O and 
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incubated at room temperature for 10 min. After the final centrifugation at 14000 xg for  
5 min, the supernatant containing the DNA was transferred into a new tube. 
 
2.2.1.2 Isolation of genomic DNA from tissue samples 
 
Lysis buffer I:      100 mM Tris-HCl (pH 8.0) 
       100 mM NaCl 
100 mM EDTA 
 0.2 mg/ml Proteinase K 
0.5% SDS 
 
The method employed was the same as that of Laird et al. (1991). 1 to 2 cm of the tail from 
a mouse was incubated in 700 µl of lysis buffer containing 35 µl proteinase K (10µg/µl) at 
55°C overnight. Equal volume of phenol was added, mixed by inverting, and centrifuged at 
8000 xg at room temperature for 10 min. After transferring the aqueous layer into a new 
tube, the same procedure was repeated, but this time with 0.5 Vol phenol and 0.5 Vol 
chloroform. Then, the DNA was precipitated with 2.5 Vol 100% ethanol, washed with 
70% ethanol, and dissolved in 100-200 µl of 1x TE buffer. 
 
2.2.1.3 Isolation of genomic DNA from ES cells 
 
Lysis-buffer II:      100 mM Tris-HCl (pH 8.5) 
    5 mM EDTA 
200 mM NaCl 
      100 µg /ml proteinase K    
0.2% SDS 
 
To isolate the DNA from the ES cells, cells were washed with PBS and incubated 
overnight in 500 µl lysis buffer II at 55°C. Equal volume of isopropanol was added and 
mixed for 15 min. After washing with 70% ethanol, DNA was transferred into 60 µl TE 
buffer. 
Materials and Methods 22
 
2.2.1.4 Isolation of total RNA from tissue samples and cultured cells 
 
TRI Reagent (Sigme, USA) is an improved version of the single-step method for total 
RNA isolation. The composition of TRI Reagent includes phenol and guanidine 
thiocyanate in a mono-phase solution. 100-200 mg tissue sample was homogenized in 1-2 
ml of TRI Reagent by using a glass-teflon homogenizer. The sample volume should not 
exceed 10% of the volume of TRI Reagent used for the homogenization. To isolate total 
RNA from cultured cells, 350 µl of TRI Reagent was added to the petri dish (6 cm 
diameter). Cells were homogenized with a rubber stick and the lysate was transferred into 
an Eppendorf tube. The homogenate was incubated at room temperature for 5 min to 
permit the complete dissociation of nucleoprotein complexes. Then, 0.1-0.2 ml of BCP was 
added which is a less toxic chemical than chloroform, shaked vigorously, and stored at 
room temperature for 15 min. After centrifugating of the sample at 12000xg for 15 min at 
4°C, the colorless upper aqueous phase was transferred into a new tube. The RNA was 
precipitated by adding 0.5 ml of isopropanol. Finally, the pellet was washed with 75% 
ethanol, and dissolved in 80-100 µl DEPC-H2O. 
 
2.2.2 Determination of the nucleic acid concentration 
 
The concentration of nucleic acids was determined photometrically by measuring 
absorption of the samples at 260 nm. DNA quality i.e. contamination with salt and protein 
was checked by the measurements at 230, 280, and 320 nm. The concentration was 
calculated according to the formula: 
C = (E 260 – E 320) x  f x c 
C = concentration of sample (ug/ul) 
E 260 = ratio of extinction at 260 nm 
E 320 = ratio of extinction at 320 nm 
f = dilution factor 
c = concentration (standard) / absorption (standard) 
for double stranded DNA : c = 0.05 ug/ ul 
for RNA : c = 0.04 ug/ul 
for single stranded DNA : c = 0.03 ug/ul 
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2.2.3 Enzymatic modifications of DNA 
 
2.2.3.1 Restriction of DNA 
 
Restriction enzyme digestions were performed by incubating double-stranded DNA with 
an appropriate amount of restriction enzyme in its respective buffer as recommended by 
the supplier, and at the optimal temperature for that specific enzyme. Standard digestions 
include 2-10 U enzyme per microgram of DNA. These reactions were usually incubated 
for 1-3 hr to ensure complete digestion at the optimal temperature for enzyme activity, 
which was typically 37°C. 
 
2.2.3.2 Ligation of DNA fragments 
 
The ligation of an insert into a vector was carried out in the following reaction mix: 
 
    30 ng vector DNA 
    50-100 ng insert DNA 
    1 µl ligation buffer (10 x) 
    1 µl T4 DNA ligase (5U/µl) 
    in a total volume of 10 µl. 
 
Blunt-end ligations were carried out at 16°C overnight, whereas sticky-end ligations were 
carried out at room temperature for 2-4 hr. 
 
2.2.3.3 TA-Cloning 
 
Taq and other polymerases have a terminal transferase activity which results in the non-
templated addition of a single nucleotide to the 3'-ends of PCR products. In the presence of 
all 4 dNTPs, dA is preferentially added. This terminal transferase activity is the basis of the 
TA- cloning strategy. For cloning of PCR products, the pGEM-T Easy Vector system 
which has 5‘ T overhangs was employed. The followings were mixed:  
 
50 ng of pGEM-T or pGEM-T Easy Vector  
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PCR product ( 3:1 vector : insert ratio) 
1 µl T4 DNA Ligase 10x buffer 
1 µl T4 DNA Ligase 
in a total volume of 10 µl 
 
The content was mixed by pipetting and the reaction was incubated overnight at 4°C. For 
transformation of the ligation reaction, JM 109 competent cells were used. 
 
2.2.3.4 Filling-up reaction 
 
0.1-4 µg of digested DNA was mixed with 0.05 mM dNTPs and 1-5 U of Klenow 
fragment. The reaction was incubated at 37°C for 10 min, then stopped by heating at 75°C 
for 10 min. 
 
2.2.4 Gel electrophoresis 
Gel electrophoresis is the technique by which mixtures of charged macromolecules, 
especially nucleic acids and proteins, are rapidly separated in an electrical field. 
 
2.2.4.1 Agarose gel electrophoresis of DNA 
 
Agarose gels are used to electrophorese nucleic acid molecules from as small as 150 bases 
to more than 50 kilobases, depending on the concentration of the agarose and the precise 
nature of the applied electrical field (constant or pulse). 1 g of agarose was dissolved in 
100 ml 0.5x TBE buffer, and boiled in the microwave, then cooled down to about 50°C 
before adding 3 µl ethidium bromide (10 mg/ml). The gel was poured into a horizontal gel 
chamber.  
 
2.2.4.2 Agarose gel electrophoresis of RNA 
 
Single-stranded RNA molecules often have complementary regions that can form 
secondary structures. Therefore, RNA was run on a denaturing agarose gel which 
contained formaldehyde, and additionally was pre-treated with formaldehyde and 
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formamide. 1.25g of agarose was dissolved in 100 ml of 1x E-Buffer, after cooling it to 
about 50°C, 25 ml of formaldehyde (37%) was added, stirred and poured into a vertical gel 
chamber. RNA samples were treated as follows: 
10 - 20µg RNA 
    2 µl 10 x E-Buffer 
    3 µl Formaldehyde 
    8 µl Formamide (40%) 
    1.5 µl Ethidium bromide 
 
Samples were denatured at 65°C for 10 min and chilled on ice before applying to the gel. 
The gel was run at 80 V at 4°C for about 3-4 hr. 
 
2.2.5 Preparation of competent E.coli bacteria 
 
Competent bacteria are characterized by a physical cell wall modification which 
facilitates DNA uptake. LB medium (100ml) was inoculated with a single colony of 
E.coli (strain DH5α) and the culture was grown at  37°C to OD 600 = 0.6. Bacteria 
were centrifuged (10 min, 4°C, 3000 xg) and the pellet was resuspended in 50 ml of 
sterile 50 mM Ca Cl2 solution (4°C) and incubated on ice for 30 min. The suspension of 
bacteria was centrifuged (10 min, 4°C, 3000 xg) and the pellet was resuspended in 10 
ml of sterile 50 mM Ca Cl2 (4°C) with 15% glycerol. The mixture was dispensed into 
aliquots of 100 µl and stored at -80°C. 
 
2.2.6 Transformation of competent bacteria 
 
Transformation of the bacteria was done by gently mixing one aliquot of competent 
bacteria (50 µl) with 10 µl of ligation reaction. After incubation for 30 min on ice, 
bacteria were heated for 45 sec at 42°C, cooling down for 3 min on ice. After adding 
300 µl of LB medium, bacteria were incubated at 37°C, 200 xg for 1hr to allow 
antibiotic resistance expression and were plated out on LB-agar plates containing 
antibiotic (50µg/ml), 1 mM IPTG and X-Gal 40mg/ml. X-Gal develop “Blue-White” 
screening  
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2.2.7 Blotting techniques 
 
2.2.7.1 Southern blotting of DNA to nitrocellulose filters 
(Southern, 1975)  
 
In Southern blotting, the transfer of denatured DNA from agarose gels to nitrocellulose 
membrane is achieved by capillary flow. 20x SSC buffer, in which nucleic acids are highly 
soluble, is drawn up through the gel into the nitrocellulose membrane, taking with it the 
single-stranded DNA which becomes immobilized in the membrane matrix. After 
electrophoresis of DNA, the gel was shaken in 0.25 M HCl for depurination. It was 
followed by shaking it further in denaturing solution for 30 min, and 45 min in neutralizing 
solution. The transfer of the DNA to the nitrocellulose membrane took place through  
a Turbo-Blot-apparatus (Schleicher & Schuell, Dassel). About 26 Whatman filter papers 
(GB-003) were layed on a Stack Tray followed by 4 Whatman filter papers (GB-002) and 
1 Whatman filter paper GB-002 soaked with 20x SSC . The equilibrated nitrocellulose 
filter which was soaked with 20x SSC was added to the top . The agarose gel was placed 
on the filter, and was covered with 3 Whatman filter papers GB-002 soaked with 20x SSC. 
The buffer tray was placed and filled with 20x SSC . Finally the buffer wick which was 
soaked with 20x SSC, and the wick cover were put on the top of the blot. The transfer was 
carried out overnight. Finally, after disassembling of the blot, the filter was washed shortly 
in 2x SSC and the DNA was fixed onto the filter by either baking it at 80°C for 2 hr or by 
UV-crosslinking ( UV Stratalinker 1800, Stratagene, USA). 
 
 2.2.7.2 Northern blotting of RNA onto nitrocellulose filters 
 
For the transfer of RNA onto a nitrocellulose filter, the same procedure as above (2.2.7.1) 
was performed. In this case, however, the RNA does not need to be denatured, but was 
transferred directly onto the filter. 
 
2.2.8 „Random Prime“ method for generation of 32P labelled DNA 
(Feinberg and Vogelstein, 1989) 
 
Ready-To-Go DNA labelling kit (Pharmacia, UK) was employed for labelling of DNA 
probes. The method depends on the random priming principle developed by Feinberg and 
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Vogelstein (1989). The reaction mix contained dATP, dGTP, dTTP, Klenow fragment (4-8 
U) and random oligodeoxyribonucleotides. 25-50 ng of DNA were denatured in a total 
volume of 46 µl at 95°C for 15 min. After pipetting the denatured probe to Ready-To-Go 
reaction cup, 4 µl of [α-32P] dCTP (3000 Ci/mmol) was added to the reaction mixture. The 
labelling reaction was carried out at 37°C for 1-3 hr. 
 
2.2.9 Non-radioactive dye terminator cycle sequencing 
 
Non-radioactive sequencing was performed with the Dye Terminator Cycle Sequencing-
Kit (ABI, Weiterstadt). The reaction products were analysed with automatic sequencing 
equipment, namely 373A DNA Sequencer (ABI, Weiterstadt). For the sequencing reaction, 
four different dye labelled dideoxy nucleotides were used, which, when exposed to  
an argon laser, emit fluorescent light which can be detected and interpreted. The reaction 
was carried out in a total volume of 10 µl containing 1 µg plasmid DNA or 100-200 ng 
purified PCR products, 10 pmol primer and 4 µl reaction mix (contains dNTPs, dideoxy 
dye terminators and Taq DNA polymerase). Elongation and chain termination take place 
during the following program in a thermocycler: 5 min denaturation followed by 25 cycles  
at 95°C, 30 sec; 55°C, 15 sec, annealing; 70°C, 4 min, elongation. After the sequencing 
reaction, the DNA was precipitated with 1/10 Vol 3 M NaAc and 2.5 Vol 100% ethanol. 
The pellet was dissolved in 4 µl of loading buffer, denatured at 95°C for 3 min, and finally 
loaded onto the sequence gel. 
 
2.2.10 Hybridization of nucleic acids 
 
The membrane to be hybridized was equilibrated in 2x SSC and transferred to  
a hybridization bottle. After adding 10 ml of hybridization solution, the membrane was 
incubated for 2 hr in the hybridization oven at an appropriate temperature which was 
usually 65°C. Then, the labelled probe and 10 µg/µl salmon DNA were denatured at 95°C 
for 10 min and added to the hybridization solution. The hybridization was carried out 
overnight in the oven. Next day, the filter was washed for 10 min with 2x SSC at room 
temperature, then with 2x SSC and 0.2x SSC at the hybridization temperature. Finally it 
was washed with 0.2x SSC containing 0.1 % SDS at the hybridization temperature. After 
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drying the filter, it was sealed in Saran wrap, and exposed to  auto radiography overnight at 
-80°C. 
 
2.2.11 Genotyping of the pelota knockout mice by using PCR 
 
The genotypes of all offspring of pelota mutant mice were analysed by polymerase 
chain reaction (PCR). For amplification of the wild-type and the mutant pelota allele, 
the DNA was extracted from mouse tails as described in 2.2.1.2 and  pipetted to the 
following reaction mixture: 
 
1 µl DNA (300-500 ng) 
1µl Primer 1 (10 pmol/ml) 
1µl Primer pelo R (10 pmol/ml) 
1µl mpGk primer 
1ml dNTPs (10 mM) 
5 ml Taq-Polymerase buffer (10x) 
0.5 ml Taq-Polymerase (5 U/ml, Amersham) 
 ad 50 ml ddH2O 
 
The mixture was covered with mineral oil and the reaction mixture was subjected to the 
following program in the thermocycler:  
 
30 sec  at 94°C   Denaturation 
60 sec  at 60°C   Annealing 
60 sec  at 72°C   Elongation 
 
Before beginning of the first cycle, DNA template was denatured for 4 min at 95°C.  
 
2.2.12 Reverse transcriptase PCR (RT-PCR) 
 
Total RNA (1-5µg) was mixed with 1 µl of oligo (dT)18 primer (10 pmol/µl) in a total 
volume of 11 µl. To disrupt the secondary structure of the RNA, which might interfere 
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with the cDNA synthesis, the mixture was heated at 70°C for 10 min, and then quickly 
chilled on ice. After a brief centrifugation, the following components were added to the 
mixture: 
 
4 µl 5 x First Strand buffer    
 2 µl 0.1 M DTT     
 1 µl 10 mM dNTPs     
 1 µl Rnasin (10 U/ ul) 
 
The content of the tube was mixed gently and incubated at 42°C for 2 min. Then 1µl of 
reverse transcriptase enzyme (SUPERSCRIPT II RNase H-Reverse Transcriptase, 
GibcoBRL Life Technologies, USA) was added, and further incubated at the same 
temperature for 1hr. The reaction was inactivated by heating at 70°C for 15 min. 10% of 
the first strand cDNA reaction was used for the PCR reaction.  
 
    10 µl 10 x PCR buffer    
     3 µl 50 mM KCl     
     2 µl 10 mM dNTP mix    
     1 µl primer 1 (10 pmol/ ul)    
     1 µl primer 2 (10 pmol/ ul)    
     1 µl Taq DNA polymerase (5 U/ul)   
     2 µl cDNA (from first strand reaction)  
     80 µl H2O 
 
The reaction was first heated to 94°C for 3 min and then subjected for 35 cycles of PCR 
amplification.  
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2.2.13 Histological techniques 
 
2.2.13.1 Tissue preparation for paraffin-embedding 
 
Bouin’s Solution     15 ml Picric acid   
   5 ml 37% Formaldehyde  
   1 ml Acetic acid 
 
The freshly prepared embryos were fixed in Bouin’s solution for 24 hr to prevent the 
alterations in the cellular structure. The tissue to be embedded in paraffin should be free of 
water. The dehydration process was accomplished by passing the tissue through a series of 
increasing alcohol concentrations. For this purpose, the tissue was let in 30%, 70%, 90%, 
and 100% (2x) ethanol for 1hr at room temperature. Later, the alcohol was removed from 
the tissue by incubating it in methylbenzoat overnight. It was then incubated in 5 ml of 
histoclear (Xylol) for 10-30 min at room temperature. The second histoclear was not 
discarded but 5 ml of paraplast was added and the incubation was continued at 60°C for 
another 30 min. The histoclear and paraffin mixture was discarded, and the tissue was 
further incubated in 5 ml of paraplast at 60°C overnight. Before embedding, the paraffin 
was changed at least three times. Finally, the tissue was placed in embedding mold and 
melted paraffin was poured into the mold to form a block. The block was allowed to cool 
and was then ready for sectioning. 
 
2.2.13.2 Sections of the paraffin block 
 
The paraffin blocks were pre-cut to the optimal size and clamped into the microtom (Hn 40 
Ing., Nut hole, Germany). The cut-thickness of the paraffin embedded was for 7 µm. The 
sections were floated on 40°C water to allow actual spread and subsequently put onto pre-
treated slides. In order to achieve a better adhesion of the sections, the slides were treated 
with a drop of serum-formalin. A fine brush was used to transfer the sections to the pre-
treated slides. After complete evaporation at 37°C for 2-5 days, slides were stored at 4°C 
for further analysis. 
 
Serum-Formalin:    15 ml   Fresh serum 
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      15 ml   Glycerin 
      6 ml   Formalin6% 
 
2.2.13.3 Staining of the histological sections 
 
2.2.13.3.1 Haematoxilin and eosin staining 
 
The stored slides with the paraffin sections were stained by the following method: 
 
1. Slides were incubated three time in histoclear (Xylol) for 3 min. 
2. Incubation in 100%, 96%, 80%, 70% and 50% ethanol for 2 min. 
3. 1 min in dH2O and then 7 min in haematoxilin Harris. 
4. Running tap water (control) for 10 min, then 1 min in dH2O. 
5. Eosin 0.1% + 2 drops acetic acid for 5 min, then in dH2O for 1 min. 
6. Incubation in 50%, 70%, 80%, 90%, 96% and 100% ethanol for 2 min. 
7. Slides were incubated two time in histoclear (Xylol) for 3 min. 
 
2.2.14 DNA ploidy analysis. 
 
To determine the DNA content in cell of cultured blastocysts, blastocysts were 
recovered from uteri of heterozygous females mated with heterozygous males, cultured 
separately as described in 2.2.18.3. After two days in culture, cells were trypsinized and 
spread onto glass slides, fixed in acetone at –20°C and quantitatively stained for DNA 
content by the Feulgen reaction using manufacturer’s protocols (Becton Dickinson, 
Hamburg). Quantitative DNA analysis (QDA) was performed by the cell analysis 
system (CAS-200) image. Calibration was performed by using the mouse leukocytes. 
For DNA content in cells of embryos at E7.5, histological sections of embryos were 
prepared. Cells of the embryo were marked under microscope before CAS image 
analysis. 
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2.2.15 Feulgen staining (DNA mass) 
 
Paraffin sections were incubated in 5N HCl for 60 min and then in the Feulgen staining 
solution for 1hr (CAS DNA staining kit by Cell Analysis System, Becton Dickinson, 
Hamburg). Afterwards, slides were rinsed in acid alcohol, cleaned in xylene and 
covered using synthetic medium. Mouse leucocytes stained with Feulgen were used as 
control cells. Slides prepared in this way were evaluated using CAS-200 image analyser 
(Becton Dickinson, Hamburg) and the quantitative DNA analysis (QDA) software 
package. DNA content was quantified by assigning an optical density to each pixel of 
an image and summing the optical density values for each nucleus. The image system 
was calibrated by measuring the DNA content of mouse leucocytes. For ploidy analysis 
100-200 cells were measured. The following parameters were evaluated: 
 
(A)    Percentage of diploid cells (DNA index 0.83-1.22) 
(B)    Percentage of aneuploid cells between 2c and 4c (DNA index 1.22-1.83) 
(C)    Percentage of tetraploid cells (DNA index 1.83-2.22) 
(D)    Percentage of aneuploid cells between 4c and 8c (DNA index 2.22-3.84) 
(E)    Percentage of octaploid cells (DNA index 3.84-4.23) 
(F)    Percentage of 16-ploid cells (DNA index 7.90-8.23) 
(ER) Exceeding rate defined as the percentage of cells with the DNA content higher 
than 5C. 
 
2.2.16 Techniques for production of targeted mutant mice 
 
The discovery that cloned DNA introduced into tissue culture cells can undergo 
homologous recombination at specific loci has revolutionized our ability to study gene 
function in vitro and in vivo. In theory, this techniqe will allow us to generate any type of 
mutation in any cloned gene. Over twenty years ago, pluripotent mouse embryonic stem 
cells (ES) derived from inner cell mass cells of mouse blastocysts were isolated and 
cultured (Martin, 1981; Evans and Kaufman, 1981). Using stringent culture conditions, 
these cells can maintain their pluripotent developmental potential even after many passages 
and following genetic manipulations. Genetic alterations introduced into ES cells in this 
way can be transmitted into the germline by producing mouse chimeras. Therefore, 
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applying gene targeting technology to ES cells in culture can give the apportunity to alter 
and modify endogenous genes and study their functions in vivo. 
 
2.2.16.1 Production of targeted embryonic stem cell clones 
 
2.2.16.1.1 Preparation of EMFI feeder layers 
 
A frozen vial of EMFI cell was quickly thawed at 37°C and transferred to 10 ml EMFI 
medium. After centrifugation at 270xg for 5 min, the cell pellet was gently resuspended in 
10 ml EMFI medium. Cells were incubated at 37°C, 5% CO2 .When the cells formed  
a confluent monolayer (three days), they were either trypisinized, transferred to five 150 
mm dishes and grown until they formed confluend monolayers, or directly treated with 
mitomycin C. To treat the EMFI with mitomycin C, the medium was removed and 10 ml 
fresh medium containing 100 µl mitomycin C (1mg/ml) was added. After 2-3 hr of 
incubation , the monolayer of cells was washed twice with 10 ml PBS. The cells were then 
resuspended with 10 ml medium and any cell aggregates were dissolved by gently 
pipetting. The cells were centrifuged, resuspended in EMFI medium and plated onto 
dishes, which were treated with 0.1% gelatine for 30 min. The feeder cells were allowed to 
attach by incubation overnight at 37°C, 5% CO2  or used after 2 hr of incubation. Before 
adding ES cells on the feeder layer, the medium was changed to ES cell medium. 
 
2.2.16.1.2 Growth of ES cells on feeder layer 
 
One vial of frozen ES cells was quickly thawed and cells were transferred to a 12 ml tube 
containing 6 ml ES cell medium. After centrifugation, the cell pellet was resuspended in 5 
ml ES cell medium and plated on 60 mm dishes containing EMFIs. The medium was 
changed the next day. The second day, cells were washed with PBS, treated with 2 ml 
trypsin/EDTA at 37°C, 5% CO2  for 5 min. The cells were gently pipetted up and down to 
dissolve cell clumps, resuspended with 5 ml ES medium and centrifuged. The cell pellet 
was resuspended in 10 ml ES cell medium and distributed either to 5 or 6 dishes (60 mm), 
containing feeder layers or to 2 dishes (100 mm) containing feeder layers. The medium 
was changed the next day, and the cells were passaged every second day as described 
above. 
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2.2.16.1.3 Electroporation of ES cells 
 
ES cells which have grown for two days on 100 mm dishes were trypsinized. The cell 
pellet was resuspended in 20 ml PBS and centrifuged .The cell pellet was then resuspended 
in 1 ml PBS. 0.8 ml of cell suspension was mixed with 40 µg of linearized DNA-construct 
and transferred into an electroporation cuvette. The electroporation was performed at 240 
V, 500 µF with the BIO RAD gene pulserTM (BIORAD, USA). After electroporation, the 
cuvette was placed on ice for 20 min. The cell suspension was transferred from cuvette into 
20 ml of ES cell medium and plated onto two 100 mm dishes containing feeder layers. The 
medium was changed the next day. Two days after the electroporation, the drugs for the 
selection were added (active G418 at 150-250 µg/ml, and gancyclovir at 2 µM). The 
medium was changed every day. After about eight days of selection, drug resistant 
colonies have appeared and were ready for screening by Southern blot analysis. 
 
2.2.16.1.4 Growing ES cells for Southern blot analysis  
 
The drug resistant colonies that were formed after about eight days of selection were 
picked with a drawn-out Pasteur pipette under a dissecting microscope. Each colony 
was transferred into a 24 well plate containing feeders and ES cell medium. After 2 
days, the ES cells were trypsinized with 100 µl trypsin for 5 min and resuspended in 
500 µl ES cell medium. Half of the cell suspension in each well was transferred to a 
well on two different 24 well plates, one gelatinised plate, and the other containing 
feeder cells (master plate). The gelatinised plate was used for preparing DNA and the 
master plate was kept frozen. 
 
2.2.16.1.5 DNA isolation from ES cell colonies 
 
The medium from each well on the gelatinised plate was aspirated. The wells were washed 
with PBS. Lysis buffer (500 µl) was added to each well in the gelatinised plate and the 
plate was incubated overnight at 37°C. To each well, 500 µl isopropanol was added and the 
suspension was shaked for approximately 15 min, until precipitated DNA become visible. 
The DNA pellet was then washed with 500 µl of 70% ethanol for 5 min, transferred into  
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an Eppendorf cup containing 50 ul of 1x TE buffer and incubated for 30 min at 60°C to 
evaporate remaining ethanol. 
 
2.2.17 Production of chimeric mice by the aggregation method 
 
2.2.17.1 Recovery of eight-cell stage embryos 
 
Pregnant females were killed on the third day of pregnancy (2.5 day post-coitus) by 
cervical dislocation. The skin and peritoneum were opened with a large transverse 
incision to expose the abdominal cavity. The oviducts with the upper part of the uterus 
were dissected and placed into a drop of M2 medium. Under dissecting microscope, the 
needle attached to a 1 ml syringe was inserted in the fimbrial end of the oviduct. The 
needle was then holded with the forceps and the oviducts were flushed with 0.05 ml of 
M2 medium. Embryos were collected with a mouth pipette and washed through several 
M2 drops. To remove the zona pellucida, embryos were treated in one drop of Tyrode’s 
acid and then transferred into the drop of M16 as soon as their zona dissolved. The 
embryos were washed through two to three drops of M16 before transferring them into 
the aggregation plate. 
 
2.2.17.2 Assembly of ES cell aggregation chimeras 
 
To prepare the ES cells for the aggregation, a plate with ES cells was rinsed with 3 ml of 
trypsin. The cells were incubated for 5 min at 37°C until they formed clumps of loosely 
connected cells, then 5 ml of ES medium was added. Under the dissecting microscope  
a number of clumps of loosely connected cells were transferred to a drop containing 
embryos in the aggregation plate. Several drops of  M16 were pipetted in the aggregation 
plate and covered with mineral oil. In each drop, five small depressions were made in the 
plastic with a darning needle that serve as cradles for the aggregation. The walls of the 
depression bring the embryos and ES cells into close proximity and therefore promote 
their aggregation. To assemble the aggregation, one clump of ES-cells (usually 10-15 
cells) was transferred to a depression containing embryo. The aggregation plate was 
incubated overnight at 37°C and 5% CO2. Usually more than 90% of ES-morulae 
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aggregated overnight to form early blastocysts. These blastocysts were collected from the 
depressions and transferred directly into the uterus of pseudopregnant females. 
 
2.2.18 Techniques for recovery, culture and genotyping 1.5, 2.5 and 3.5 days old 
embryos 
 
2.2.18.1 Recovery of 1.5 and 2.5 days old embryos 
 
1.5 and 2.5 days old embryos are present in the oviduct 30-60 h post coitus (pc). By this 
time, the embryos have lost their cumulus cells and they can be flushed from the 
oviduct. To isolate the 1.5 and 2.5 days old embryos, pregnant mice (1.5 and 2.5 days  
pc) were killed by cervical dislocation. The dissection of the oviducts and recovery of 
embryos was done as described before (2.2.17.1). The collected embryos were washed 
five times in a drop of PBS and each single embryo was transferred into an Eppendorf 
tube containing 5 µl PBS.   
 
2.2.18.2 Recovery of blastocysts (3.5 dpc) 
 
Blastocysts can be flushed easily from the uterus between 3.5 and 4.5 days (pc). On the 
fourth day of pregnancy (3.5 days pc) mice were killed by cervical dislocation. The skin 
and peritoneum were opened with a large transverse incision to expose the abdominal 
cavity. The uterus was grasped with a forceps above the cervix and cut with fine scissors. 
Then, the uterus was cut below the junction to the oviduct, placed into M2-medium and 
both horns were flushed with about 0.2 ml of M2-medium. The collected blastocysts were 
washed five times in a drop of PBS. Single blastocysts were transferred into an Eppendorf 
tube containing 5 µl H2O and genotyped by PCR.  
 
2.2.18.3 Culture of the blastocysts and genotyping 
 
The collected blastocysts were washed five time in drops of PBS and then transferred into 
a well of a 96-well plate containing 20 µl of ES medium. The 96-well plate was incubated 
at 37°C, 5% CO2 for five days. Cultured embryos were washed twice with PBS and 
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incubated with 20 µl lysis buffer for 5 hr at 37°C. The embryonic extract was transferred 
into an Eppendorf tube and boiled for 5 min. 5 µl of the extract were used for the PCR-
assay. 
 
2.2.19 Chromosomal preparation of embryonic cells  
 
After culturing of blastocyst for 48-72 hr , 3 µl Nocodazol (1 µg/ml ) was added to 30 µl of 
culture medium and cells were further incubated for 6 hr at 37°C, 5% CO2. Cells were 
washed twice with PBS, trypsinized with 30 µl trypsin and incubated at 37°C, 5% CO2 for 
5 min. Trypsin was inactivated with 150 µl of ES cell medium. Cells were resuspended 
two times with a micropipette, transferred in an Eppendorf tube and centrifuged at 250 xg 
for 5 min. After resuspension in 100 µl of 75 mM KCl (0.563%) cells were incubated for 
20 min at 37°C and centrifuged at 500 xg for 5 min. After removing of the KCl, cells were 
fixed in 100 µl ice cold methanol/acetic acid 3 : 1 (Vol/Vol) for 10 min at 4°C and 
centrifuged at 650 xg for 5 min. Fixation step was repeated. Finally, cells were 
resuspended in 15 µl of fixative solution and dropped onto prewarmed (37°C) glass slides. 
Slides were stained with Giemsa (5% Giemsa in PBS buffer) for 10 min and washed under 
running tap water for 3 min.  
 
2.2.20 Transfection of cells  
 
2.2.20.1 Transfection of NIH – 3T3 cells with the GFP-pelota construct 
 
Approximately 4 x 105 fibroblast cells 3T3 were plated in a cell chamber with slide 
(Lab-Tek, Flaskett glass slide, Nanc international, Naperville) and cultured overnight in 
5 ml DMEM medium containing 10% FCS and pencillin/streptomycin at 37°C and  
5% CO2. 1µg of DNA (GFP-pelota) was deluted with the DNA- condensation buffer 
(buffer EC of the Effection Transfection kit Qiagen, Hilden) to a total volume of 150 µl, 
8 µl of enhancer was added to DNA and mixed by vortexing for 1 sec. The mixture was 
incubated at RT for 5 min. 25 µl of Effectin Transfection Reagent was added to the 
DNA-Enhancer mixture, mixed by pipetting and incubated for 10 min at RT to allow 
complex formation. 1 ml of cell medium was added to the reaction tube, mixed and 
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immediately added into the cell chamber. Cells were incubated overnight at 37°C and 
5% CO2 to allow for gene expression. The glass slide of the culture chamber was rinsed 
with PBS and then fixed with methanol for 5 min. One drop of mounting medium with 
DAPI (Vector, Burfingame) was dispensed onto the slide. Fluorescent cells were 
visualised with a Olympus BX60 microscope using a 60X Neofluor lens, photographed 
using digital camera and analysed using analysis 3.0 soft imaging system. 
 
2.2.20.2 Transfection of ES cell with the GFP-pelota construct 
 
ES cells were electroporated with the linearized GFP-pelota construct as described in 
2.2.16.1.3. Transfected ES cells were cultured for 10 days in ES medium containing  
400 µg/ml G418. Resistant ES-clones were picked, trypsinized and each clone was 
transferred to a well of 24 well plate. The cells were cultured for another two days at 37°C, 
5% CO2 , and frozen as described in section 2.2.16.1.2. 
 
2.2.21 Immunostaining 
 
Recombinant GFP-Pelota-ES cells were treated with trypsin for 5 min at 37°C and 
centrifuged at 250 xg for 5 min. Cells were resuspended in 4% paraformaldhyde / PBS for 
15 min and dropped onto a glass slide. Slides were blocked in PBS with 10% FCS for 30 
min, then incubated with anti-γ-tubulin monoclonal antibody (Sigma GTU-88) at 1 : 200 
dilution in PBS with 4% FCS for 1 hr, washed three times with PBS, incubated with  
a FITC-conjugated donkey anti-mouse IgG antibody (Sigma, 1 : 200 dilution) in PBS for  
1 hr, washed three times in PBS and then mounted in vectashield with DAPI. 
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3 RESULTS 
 
3.1 Expression of mouse pelota gene 
 
3.1.1 Expression of the pelota gene in different tissues of the adult mouse and during 
prenatal development of the mouse 
 
To determine the expression of pelota gene in different tissues of the adult mouse, 20 µg of 
total RNA from testis, spleen, liver, lung, heart and brain was size fractionated in 1% 
agarose gel containing formaldehyde and transferred to nitrocellulose membranes. 
Equivalent loading and integrity of the RNA samples were confirmed by staining of the 
28S and 18S rRNA with ethidium bromide in the gel before transferring onto nitrocellulose 
membranes (Fig. 3.1 B). The Northern blot was hybridised with 32P-labeled mouse pelota 
cDNA. A 1.6 kb transcript of the pelota gene was detected in the RNA of all studied 
tissues. An additional  2.1 kb pelota transcript was observed in RNA of the spleen (Fig. 3.1 
A). The results of Northern blot hybridization suggest that the 1.6 kb transcript is 
expressed ubiquitously, while the 2.1 kb transcript is exclusively expressed in the spleen.  
To investigate the expression of the pelota gene during prenatal development, RNA was 
extracted from the posterior part of 9.5, 10.5, 11.5, 12.5, 13.5, 15.5 and 17.5 dpc embryos 
and analysed for the presence of pelota transcript by RT-PCR using the primer F7 and R7 
(Fig. 3.3). A 500 bp amplified product was observed in all studied stages of embryos  
(Fig. 3.2).   
 
3.1.2 Expression of mouse pelota gene during testicular development and in the testis 
of different mutant mice  
 
To evaluate the expression of the pelota gene during testicular development, Northern 
blots with testicular RNAs from 5-, 10-, 15-, 20-, 25- and 60- day old mice were hybridised 
with 32P-labeled mouse pelota cDNA. As shown in Figure 3.4, a 1.6 kb pelota transcript 
was detected throughout testis development. 
To examine whether the expression of the pelota gene is restricted to spermatogenic cells 
of the testis, Northern blot analysis with testicular RNA isolated from W/Wv, Tfm/Y, 
olt/olt and qk/qk mutant mice was performed. As shown in Figure 3.5, a 1.6 kb pelota 
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transcript is expressed in testes of W/Wv mutant mice, which lacks spermatogenic cells, in 
testes of Tfm/Y mice, in which spermatogenesis is arrested at the stage of primary 
spermatocytes and in testes of olt/olt and qk/qk mutant mice, in which spermatogenesis is 
arrested in spermatid stages. These results indicate that the expression of the pelota gene is 
not restricted to spermatogenic cells of the testis.  
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Figure 3.1: Northern blot analysis of pelota gene expression in adult mouse tissues. Total
RNA (20 µg) was extracted from various tissues (testis, spleen, kidney, liver, lung, heart and
brain) of the adult mouse and subjected to Northern blot hybridization using the pelota
cDNA as a probe (A). Equivalent loading and integrity of the RNA samples were confirmed
by ethidium bromid staining of 28S and 18S rRNA in the gel before transferring RNA to
nitrocellulose membranes (B).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Results 41
 
 
 
 
 
 
 
 
 
 
 
10
.5
11
.5
12
.5
13
.5
15
.5
17
.5
Ad
ult9.5M 
--Pelo 
Figure 3.2: RT-PCR analysis of pelota gene expression during fetal
development. RNA was isolated from the abdomen of single mouse embryos
of different ages and was reverse transcripted using oligo (dT)17 primer.
Subsequent PCR amplification was performed with oligonucleotide primers
F7 and R7 (Fig. 3.3). The RT-PCR products were electrophoresed on a 1.5%
agarose-gel and stained with ethidium bromide; a 500 bp pelota cDNA
fragment was amplified. M, corresponds to molecular weight marker. 
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 aaccaccaccacccccgcaaacacaccaacctctaagaaagatggctgacatcagttaacacgattaaccctccctttaacctcc 85 
tctcctcaattaaggctctgctttaaaatccttacacaaaacgcagtgagcgagcctaagtggtcaggatttctctgctcccccc 170 
actgtcttcattcagaaagagacttctctgtatttccatcgccactgtaccaaaggggatgggagaaacggaatggatttttgtt 255 
tatttgtttttctttttcttttcttttcctttacaaccaactctttggctcttcttttggggtggtcatattagattagcttatc 340 
tttacttcccatctcctcaacttttggctagtcagtggaagggagatcgagcgctaatctactgcagtccggctcccacactgaa 425 
ACGCCTCAGAGACTACTGCGCTGAGGCTGCCAACTTTGGATTCTGGGATTCCCAGGACATCAATCAGGTCAAGCTACATAGAGGT 510 
CCACCAGGGGTACATTCCACGCATTCCACTGCTCTCTCTGGGCTCTGTCCTTTAACATCTGGGTTAACTGGATCGTGCAAACAGG 595 
GTAACAGGCGCAGAAAACAGCTGGACACGTTGCTGAGCCCAGACTGTACGTGACTAGTTCTTAGAAACCGCTTCTGGATCTCTCT 680 
GAGCCAACAAGCTCGTCGGTCTGAGTGCTGGTAGGGAAAGAGCGAGCAAAGCCAGGCAGAGtttgaacttcgccggggatggggg 741 
gggcaagtctgaacttttgagggcgcttttcacttttatataagttctgaagctggcttcacgctaaggtgcagaatgataaatc 
cagcttaaatacatatgtttgcattcacgtacttggcatgttctcgcacacagggatgttccgggaaaagcttagcttttcagag 
cgctgaccgcctcctttgacgtttatctagggcgagcctttccttttactgcgcctgcgtgcgcgcgccgccgacaggccccgcc 
tctctggtagggacccacaacagacttgcgccgggaggcgggctgcgcctgcgcgatcgccgcgtcagccggtttcgcggggccg 
gcgactggaagtcccgagagttgactctggctgagcgtgaggtttgccgcgccgcgccgcgcgtgggccagcgcgcggagacttg 
agaaaaagcgtggggtaaaagtgctgtcccgagctgcaagagttagaggtagtgtttccttccGggcctgaccggccgcccttcc 
tgccccggccccccttcctggggaaaccccccccccccctagcgtcccctgttctgaactgagcccctgctgag 
GTC ATG AAG CTC GTG AGG AAG  762 
                                                           M   K   L   V   R   M  6    
GAT ATC GAG AAG GAC AAT GCG GGC CAG GTC ACC CTC GTC CCC GAG GAG CCC GAG GAC ATG TGG 825 
D   I   E   M   D   N   A   G   Q   V   T   L   V   P   E   E   P   E   D   M   W   27  
CAC ACC TAC AAT CTA GTG CAG GTG GGC GAC AGC CTG CGC GCC TCC ACC ATC CGC AAG GTC CAG 888 
H   T   Y   N   L   V   Q   V   G   D   S   L   R   A   S   T   I   R   K   V   Q    48 
ACC GAG TCC TCC ACG GGC AGC GTG GGG AGC AAC CGT GTC CGC ACC ACC CTC ACC CTT TGC GTG 951 
T   E   S   S   T   G   S   V   G   S   N   R   V   R   T   T   L   T   L   C   V    69 
GAG GCC ATC GAC TTC GAC TCC CAG GCC TGC CAG CTG CGG GTG AAG GGG ACC AAT ATC CAA GAA 1014 
E   A   I   D   F   D   S   Q   A   C   Q   L   R   V   K   G   T   N   I   Q   E    90 
AAA GAG TAT GTC AAG ATG GGG GCT TAC CAC ACC ATC GAA CTG GAG CCC AAC CGC CAG TTC ACC 1077 
K   E   Y   V   K   M   G   A   Y   H   T   I   E   L   E   P   N   R   Q   F   T    111 
CTG GCC AAG AAA CAG TGG GAC AGT GTG GTT CTG GAA CGC TTC GAG CAG GCT TGC GAC CCG GCG 1140 
L   A   K   K   Q   W   D   S   V   V   L   E   R   F   E   Q   A   C   D   P   A    132 
TGG AGC GCT GAT GTG GCA GCT GTG GTC ATG CAG GAG GGC CTG GCC CAC GTC TGC TTA GTC ACT 1203 
W   S   A   D   V   A   A   V   V   M   R   E   G   L   A   H   V   C   L   V   T    153 
CCC AGC ATG ACC CTT ACC CGG GCC AAG GTG GAG GTG AAC ATC CCC AGG AAA CGG AAA GGC AAC 1266 
P   S   M   T   L   T   R   A   K   V   E   V   N   I   P   R   K   R   K   G   N    174 
TGC TCC CAG CAT GAC CCG GCC CTG GAG CGG TTC TAT GAA CAG GTG GTC CAG GCC ATC CAG CGC 1329 
C   S   Q   H   D   P   A   L   E   R   F   Y   E   Q   V   V   Q   A   I   Q   R    195 
CAC ATA AAC TTC GAG GTT GTA AAG TGC GTT CTG GTG GCC AGC CCT GGA TTC GTG CGA GAG CAG 1392 
H   I   N   F   E   V   V   K   C   V   L   V   A   S   P   G   F   V   R   E   Q    216 
TTC TGC GAT TAC ATG TTT CAG CAA GCT GTG AAG ACG GAC AAT AAA GTG CTC CTG GAA AAC CGC 1455 
F   C   D   Y   M   F   Q   Q   A   V   K   T   D   N   K   V   L   L   E   N   R    237 
TCC AAA TTC CTT CAGgtaaaaatcttacccagagagagtttcctaatgttttaaaatggggaggagccgaagcttggctg 1470 
K   F   L   Q       241 
ggactataaatgaaattgtaactgaaccctgcagtatctagcactttaaaaagttgtccaagtccttaaacaggttaggccttat 
tcatgtgtttgtcaaatgtcatcgtgggctgattaatggatactttcaaaaattctttgtcttttataattgtgaattctag  
 
GTG CAC GCC TCC TCT GGA CAC AAG TAC TCC CTG AAA GAG GCC CTC TGC GAC CCT ACT GTA GCG 1533 
V   H   A   S   S   G   H   K   Y   S   L   K   E   A   L   C   D   P   T   V   A  262 
AGC CGC CTT TCA CAC ACA AAG GCA GCG GGC GAA GTA AAA GCC TTG GAT GAC TTC TAC AAA ATG 1596 
S   R   L   S   H   T   N   A   A   G   E   D   K   A   L   D   D   F   Y   K   M  283 
TTA CAG CAC GAG CCC GAC CGA GCG TTC TAT GGA CTC AAG CAG GTG GAG AGG GCC AAC GAA GCC 1659 
L   Q   H   E   P   D   R   A   F   Y   G   L   K   Q   V   E   R   A   N   E   A  304 
TTG GCC ATA GAC ACT TTG CTC ATC AGT GAC GAG CTC TTC CGG CAT CAG GAT GTG GCC ACC CGG 1722 
L   A   I   D   T   L   L   I   S   D   E   L   F   R   H   Q   D   V   A   T   R  325 
AGC CGG TAT GTC AGG CTG GTG GAC AGT GTG AAG GAG AAT GCG GGC ACC GTT AGG ATA TTC TCT 1785 
S   R   Y   V   R   L   V   D   S   V   K   E   N   A   G   T   V   R   I   F   S  346 
AGT CTC CAT GTG TCG GGG GAA CAG CTG GGC CAG CTG ACG GGA GTA GCC GCC ATT CTC CGC TTC 1848 
S   L   H   V   S   G   E   Q   L   G   Q   L   T   G   V   A   A   I   L   R   F  367 
CCA GTG CCA GAA CTT TCT TGAcaagaggatgattcaagttctgaagaggattaagactggcagttaatagtttcgt  1869 
P   V   P   E   L   S   *      373 
ccctggttttctcagcatccttgctgggccagagcagcacttgttgatcctgctggggtttcttgtggttgggttcacattaa 1933 
gtgttttatgatttggtgggcaggacatgtattcaaattaAATAAAtcacgacc    1988 
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Figure 3.3: Nucleotide sequence of the mouse pelota gene. Nucleotide sequences of exons are
shown in uppercase letters; 5’ and 3’ flanking regions and intronic sequences are in lowercase
letters. Numbering of nucleotide and amino acid sequences are given at the right side.
Translation intiation codon (ATG), stop codon (TGA) and AATAAA polyadenylation signal
are written in bold. The positions of primers used in this studies are marked with arrows. 
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 Figure 3.4: Northern blot analysis of mouse pelota gene expression during
testicular development. (A) Total testicular RNA isolated from 5-, 10-, 15-,
20-, 25- and 60- day old mice was hybridized with mouse pelota cDNA
fragment. (B) Equivalent loading and integrity of the RNA samples were
confirmed by ethidium bromide staining of 28S and 18S rRNA in the gel.  
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Figure 3.5: Northern blot analysis of pelota gene expression
in testes of different mutant mice. (A) Total testicular RNA
isolated from w/wv, Tfm/Y, olt/olt and qk/qk mutant mice
was hybridized with the mouse pelota cDNA fragment. (B)
Integrity of RNA was checked by staining the 28S and 18S
rRNA with ethidium bromide in the gel. 
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3.2 Homologous recombination 
 
3.2.1 Isolation and restriction mapping of the pelota gene 
 
A genomic clone (Melo1) containing the pelota gene was isolated from a genomic mouse 
phage library (Stratagen, La Jolla, CA) by Dr. R. Shamsadin (Institute of Human Genetics, 
Göttingen). A 14 kb BamHI fragment containing the pelota gene was isolated from the 
phage clone (Melo1) and was subcloned into the Bam HI site of pGEM 32f(t) vector to 
produce clone 16 kb (Fig. 3.6 A). The restriction map of the 14 kb BamHI fragment was 
determined (Fig. 3.6 A) and the mouse pelota gene was sequenced (Fig. 3.3). The mouse 
pelota gene consists of 3 exons. Exon 1 contains the 5’ untranslated sequence, while exons 
2 and 3 contain the coding sequence and the 3’ untranslated region.  
 
3.2.2 Construction of the pelota targeting vector 
 
To disrupt the pelota gene in the mouse, a replacement targeting vector was designed to 
delete the 3.1 kb SpeI/EcoRI fragment containing a sequence of exons 2 and 3 and 
replaced by the neomycin phosphotransferase (Neo) gene under the control of the 
phosphoglycerate kinase promoter. Introduction of a negative selection marker, the herpes 
simplex virus thymidine kinase (Tk) gene, at the 3’ end of the construct (Fig. 3.9) enabled 
us to use positive and negative selection (Mansour et al., 1988). 
 
3.2.2.1 Subcloning of the 16 kb pelota genomic fragment 
 
The DNA of the clone 16 kb (Fig. 3.6 A) was digested with the restriction enzyme SpeI. 
The 9 kb and 6 kb SpeI fragments were purified from the agarose gel. The 9 kb SpeI 
fragment includes a 6 kb genomic fragment and the pGEM 32f(t) vector. This fragment 
was self-ligated to give the clone 9 kb SpeI (Fig. 3.6 C). The 6-kb/SpeI genomic fragment 
was subcloned into the SpeI digested pBluescript vector to produce the clone 6 kb SpeI 
(Fig. 3.6 B). 
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3.2.2.2 Subcloning of the 3’ flanking region of the pelota gene into the pPNT vector 
 
The 4 kb HindIII/SpeI fragment located in the 3’ flanking region of the pelota gene was 
isolated from the clone 6 kb SpeI (Fig. 3.6 B) and was subcloned into the HindIII/SpeI site 
of pZero vector to create the clone 4H/S (Fig. 3.6 D). The DNA of clone 4H/S was 
digested with EcoRI and the 3 kb EcoRI fragment was purified from the agarose gel and 
ligated with the EcoRI digested pPNT vector (Fig. 3.7 A) to produce the clone 1  
(Fig. 3.7 B). 
 
3.2.2.3 Subcloning of the 5’ flanking region in the pPNT vector 
 
DNA of the clone 9 kb SpeI (Fig. 3.6 C) was digested with XbaI/SpeI, the resulting 4.8 kb 
XbaI/SpeI fragment was purified from the agarose gel and subcloned into the XbaI/SpeI 
site of the pBluescript vector to produce the clone 5X/Sp (Fig. 3.6 E). Finally, the 4.8 kb 
NotI/XhoI fragment was isolated from the clone 5X/Sp and inserted into clone 1 (Fig. 
3.7B) to give the final targeted vector pelo-Neo-Tk (Fig. 3.7 C). The DNA of the construct 
pelo-Neo-Tk was digested with different restriction enzymes to confirm the orientation of 
the cloned fragments in the pPNT vector (Fig. 3.8). The replacement vector pelo-Neo-Tk 
was linearized at the unique NotI site present in the polylinker site of the pPNT vector 
before electroporation. 
 
3.2.3 Subcloning of the 5’ external probe 
 
The 1.3 kb EcoRI/XbaI fragment was isolated from the clone 9 kb SpeI (Fig. 3.6 C) and 
inserted into the EcoRI/XbaI site of pBluescript to produce clone 1.3 E/X (Fig. 3.6 F). The 
DNA of the clone 1.3 E/X was then double digested with EcoRI/XbaI and the 1.3 kb 
fragment was extracted from the agarose gel and used as 5’ external probe for 
hybridization in the Southern blot with DNA extracted from the recombinant ES-clones.  
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 Figure 3.6: Restriction map of the clone 16 kb. The cloning strategy for subcloning the 5’ and 3’
regions of the pelota gene and subcloning of the 5’external probe. The restriction sites were elaborated
for the following enzymes shown: B, Bam HI; E, EcoR I; H, Hind III; S, Sal I; Sp, Spe I; X, Xba I;
Xh, Xho I; N, Not I. The exons of pelota are shown as color boxes. The cloned fragments were shown
as bold bars. 
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Figure 3.7: Strategy to subclone the 5’and 3’ flanking regions of the pelota gene in the pPNT
vector. Restriction sites for the following enzymes are shown: B, Bam HI; E, EcoR I; H, Hind
III; K, Kpn I; Sp, Spe I; X, Xba I; Xh, Xho I; N, Not I. The cloned fragments are shown as
bold bars.  
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Figure 3.8: The restriction digestion analysis of the targeted vector Pelo-Neo-Tk
with different enzymes to confirm the correct orientation of the 5’and 3’ fragments
of the pelota gene in pPNT vector.N, NotI; Xh, XhoI; X, XbaI, S, SpeI; H, HindIII.
M, 1 kb-DNA ladder (Gibco / BRL).   
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3.2.4 Electroporation of the RI ES-cells and screening of ES-clones for homologous 
recombination events. 
 
The ES cell line RI was cultured as described (2.2.16.1.2). Confluent plates were washed 
in PBS buffer, trypsinized and the cells were suspended in the same buffer at 2 x 107 
cells/ml. Aliquots of this cell suspension were mixed with 35 µg of linearized targeted 
vector pelo-Neo-Tk and electroporated at 250V and 500 µF using a Bio-Rad Gene Pulser 
apparatus. The cells were plated onto nonselective medium in the presence of G418-
resistant embryonic mouse fibroblasts. After thirty-six hours, selection was applied using 
medium containing G418 at 350 µg/ml and gancyclovir at 2µM. After 10 days of selection, 
96 individual drug-resistant clones were picked into 24-well plates. Three days later, 
individual recombinant ES-clones were replicated into 24-well trays for freezing and 
isolation of DNA. 
To screen recombinant ES-clones for homologous recombinant events, genomic DNA was 
extracted from the recombinant ES-clones, digested with EcoRI, electrophoresed and 
blotted onto nitrocellulose filters. The blots were hybridized with 32P-labelled 1.3 kb 
EcoRI/XbaI fragment, which is located 5’ to the targeted construct (5’ probe I in Fig. 3.6 
F; 3.9). In case of homologous recombination event, the wild-type locus showed a 15 kb 
EcoRI fragment and the targeted locus is 13.5 kb EcoRI fragment (Fig. 3.9). Of the 
colonies screened, 4 of 84 clones had undergone correct homologous recombination  
(Fig. 3.10). 
 
3.3 Generation of chimeric mice 
 
Of the 4 homologous recombinant pelota clones (Fig. 3.11), 10-15 cells of 2 homologous 
recombinant clones were aggregated independently with 2.5-day old embryos of the CD1 
mouse strain to generate chimeric mice. Cells from both targeted ES-clones yielded 4 male 
chimeras. Two chimeric males transmitted the targeted allele through their germ line to 
produce heterozygous male and female mice. Both germ line transmitting chimeras were 
bred with C57Bl/6J and 129/Sv females to establish the pelota-disrupted allele on  
a C57Bl/6J X 129/Sv hybrid and a 129/Sv genetic background. A PCR analysis using 
primers F10, R12 and pgk1 (Fig. 3.3) was performed with isolated DNAs from tail biopsies 
to determine the genotypes of the F1 offspring. A total of 118 animals in F1 generation were 
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genotyped and 53 mice were defined to be pelota+/-. Both male and female mice 
heterozygous for the pelota deletion were phenotypically normal and fertile. 
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Figure 3.9: Targeted disruption of the pelota gene. Structure of the wild-type, targeting vector and 
targeted allele are shown together with the relevant restriction sites. A 2 kb HindIII fragment 
containing exons 2 and 3 of the gene was replaced by a Pgk-neo selection cassette (Neo). Tk, Thymidine 
kinase cassette; E, EcoRI; X, XbaI; Sp, SpeI; H, HindIII; E*, EcoRI site from polylinker of phage
clone. The primers F11, R12 and pgk1 used to amplify wild-type and targeted allele in PCR assay are 
shown. 
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Figure 3.10: Analysis of  12 transfected ES cells clones by Southern blotting. The ES cells DNAs
were digested with EcoRI and hybridized with the 5’ probe I of the pelota gene (Fig. 3.6; 3.9).
Homologous recombination events resulted in a 13.5 kb-hybridizing fragment detected in
heterozygote lines (+/-). Homozygote wild-type lines (+/+) showed a 15 kb fragment.  
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Figure 3.11: Analysis of  transfected ES cells lines by Southern blotting.
The 4 homologous recombination events yielded a 13.5 kb hybridizing
fragment from the mutant allele and a 15 kb fragment from wild-type allele. 
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3.4 Pelota mutation results in early embryonic lethality  
 
Heterozygous animals were intercrossed and the offspring (240 mice) were genotyped by 
PCR analysis at age of 3 weeks (Fig. 3.12). No pelota-/- animals were detected among these 
offspring (Table 3.1). Given that mortality of neonates was not noticed during the first  
3 week after birth, this lack of pelota-/- mice indicated that pelota deficiency results in 
embryonic death. 
Northern blot with total RNA prepared from testis of pelota+/+ and pelota+/- demonstrated 
that the level of the 1.6 kb transcript in testis of pelota+/- is lower than that in testis of 
pelota+/+ (Fig. 3.13). This result suggests that the deletion of exons 1 and 2 lead to 
inactivation of the pelota gene. 
To assess the consequences of the pelota mutation for embryonic development, embryos 
were collected from heterozygous intercrosses at different days of gestation. Genomic 
DNA was isolated from whole embryos, and genotyping was performed by PCR assay 
using primers F10, R12 and pgk1 (Fig. 3.9). The PCR analysis of post-implantation embryos 
dissected from the decidua at embryonic day (E) 8.5, 9.5 and 10.5 showed that none of  
31 studied embryos was pelota-/- (Table. 3.1). However, empty deciduas, which could 
account for the resorbtion of  pelota-/- embryos were detected at E8.5. Resorbed embryos 
were also noticed at E9.5 and E10.5.   
To investigate whether the pelota deficient embryos die during preimplantation stages, 
morulae (E2.5) and blastocysts (E3.5) were isolated, and their genotypes were determined 
by PCR (Fig. 3.14 A, B). At E2.5 and 3.5, pelota-/- embryos were detected in the expected 
ratio as defined by Mendelian distribution (Table 3.1). These results suggest that pelota-/- 
embryos die between E3.5 and E8.5. 
To determine the cause and time of embryonic lethality, deciduae at embryonic day 6.5, 
7.5, 8.5 and 9.5 were dissected from uteri of heterozygous females mated to heterozygous 
males and characterised by light microscopy. The mean number of dissected 6.5-, 7.5-, 8.5- 
and 9.5-day old deciduae was not significantly different from that of the wild-type female 
mated to wild-type males (Table 3.2 ; 3.3). These results indicate that the implantation of 
pelota-deficient embryos is not affected. Furthermore, the dissected 6.5-, 7.5-, 8.5- and  
9.5-day old deciduas from heterozygous intercrosses showed no obvious morphological 
differences (Fig. 3.15 A, C, E). The embryos at E7.5, 8.5 and 9.5 were isolated from 
deciduas, microscopically examined by light microscopy and then genotyped by PCR 
assay. The wild-type embryos of stage E7.5, E8.5 and E9.5 were much larger than mutant 
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embryos (Fig. 3.16 B, D, F). However, we could not isolate embryos of stage E6.5 from 
the decidua. These embryos were too small. The 6.5-, 7.5- and 8.5-day old deciduas were 
fixed overnight in 4% paraformaldhyde, dehydrated and embedded in paraffin. Serial 
sections of 7 µm thick were cut,  stained with Giemsa and analysed. At developmental 
stage E6.5, 41 embryos were histologically examined. All embryos at E6.5 were found to 
be developed normally at this stage (Table 1 and Fig. 3.16 A, B).  However, 16 of 57 
histologically examined E7.5 (Table 3.1) showed profound developmental abnormalities 
and strikingly reduced size (Fig. 3.16 C, D). Histological analysis of 34 embryos at E8.5 
revealed that developmental delay was clearly evident by 3 embryos and 4 deciduas were 
found to lack embryos (Table 3.1 and Fig. 3.16 E, F). All three germ layers namely 
mesoderm, endoderm and ectoderm seem to be differentiated in the pelota deficient 
embryos (Fig. 3.17 A, B; 3.18 A, B). The mutant embryos have a well developed layer of 
extraembryonic ectoderm. The amniotic cavity is developed and amniotic fold consists of 
amniotic mesoderm and ectoderm. The embryonic mesoderm seems to be formed in the 
mutant embryos. However, the mutant embryos at E7.5 and E8.5 were completely lacking 
allantois and chorion (Fig. 3.17 B and 3.18 B).  
These results revealed that the development of the pelota deficient embryos up to E6.5 
appears be normal but slows down at the E 7.5. After E9.5, no viable pelota-/- embryos 
were observed.  
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 Figure 3.12: Identification of the wild-type and targeted pelota alleles in
the genome of 10 offspring from heterozygous intercrosses using a PCR
analysis. The PCR products obtained using primers F11, R12 and pgk1
(Fig. 3.3) were electrophoresed on 1.5% agarose gel and stained with
ethidium bromide. 
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Table 3.1: Viability analysis of pelota-/- mice and embryos.  
 
Total
E 6.5  41   0   0   0 
E 7.5  57   16   0   16 
E8.5  34  3 4   7
Age  Total  Abnormal (A)  Resorbed (R)  Total (A+R) 
Number of embryos from pelota+/- intercrosses
B. Histological analysis of embryos in uteri.
A. Genotype of offspring and embryos from pelota+/- intercrosses. 
Offspring   83  157  0  240 
Embryos,E8.5- E 10.5  12  19  0  31 
Blastocysts, E 3.5  10  27  11  48 
Morulae, E2.5   8  13  6  27 
Blastocysts grown in culture 
Normal at E8.5  9  20  0  29 
ICM atrophied by E8.5 0  0  5  5
pelota+/+ pelota+/- pelota-/- 
Genotype
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Mice, E8.5 - E10.5, and blastocysts were genotyped by PCR assay. All embryos harvested at
E3.5 were grown in culture to at least E 8.5 before recovering DNA for genotyping. For
histological analysis embryos were fixed, sectioned, stained, and scored as normal or abnormal
based on size and general morphology (Example shown in Fig 3.16). Empty deciduas were
scored as `` Resorbed´´.    
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Figure 3.13: Northern blot analysis of testicular RNA. Ten µg of
total RNA extracted from wild-type testis and heterozygous pelota
testis were analysed by Northern blot hybridization using the pelota
cDNA. The blot was rehybridized with the EF-2 cDNA. 
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Figure 3.14: PCR genotyping of embryos. E2.5 (A); E3.5 (B). Separate PCR
reactions were performed to amplify the wild-type allele (250 bp) and the disrupted
allele (216 bp) and the samples were then analyzed on ethidium bromide stained
agarose gel. ``M´´ indicates molecular weight markers. 
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 Table 3.2 : Mean number of 6.5-, 7.5-, 8.5- and 9.5-day old deciduas from 
heterozygous and wild-type intercrosses.   
 
                                                 Mean number 
  Developmental 
stage of decidua          Heterozygous intercrosses   Wild-type intercrosses  
 6.5-day old    8.8 (4)     10.6 (2) 
 7.5-day old   10  (6)     9.8   (2) 
 8.5-day old   9.4 (9)     10.5 (2) 
 9.5-day old   9.3 (3)     11.4 (2) 
 
Number of intercrosses are indicated in parentheses.  
 
 
 
 
 
 
Table 3.3 : Number of analysed deciduas of 6.5-, 7.5-, 8.5- and 9.5-day old 
pregnancies and results of histological analyses from heterozygous pelota intercrosses.  
 
Embryos     
% of abnormal 
embryos 
Developmental 
stage of decidua 
 
 Deciduas  Normal Abnormal  
 6.5-day old   39  39    0     0  
 7.5-day old  59  46  13   22.03  
 8.5-day old  86  68  18   20.9  
 9.5-day old  28  22    6   21.5 
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Figure 3.15: Morphology of deciduas and embryos isolated from heterozygous
pelota intercrosses. All deciduas dissected from uteri of pelota+/- females mated
with pelota+/- males at dpc 7.5 (A), 8.5 (C) and 9.5 (E) showed normal
development. In contrast two classes of embryos can be distinguished at E7.5,
E8.5 and E9.5. The mutant embryos are shown in the right sites of B, D and F.
This embryo E7.5 is smaller than its wild-type littermate. The right part of D and F
shows a severely affected mutant embryo at E8.5 and E9.5, respectively. They are
much smaller than the wild-type embryos, with no sign of organization.   
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Figure 3.16: Histological analysis of pelota mutant embryos and their wild-type or
heterozygous littermates at E6.5, E7.5 and E8.5. At E6.5, all isolated embryos from
heterozygous intercrosses exhibited normal development (A, B). At E7.5, 16 of 70
embryos were small and disorganised (D). At E8.5, 8 of 37 embryos were disorganised
or resorbed (F). 
 
 
 
 
 
 
Results 62
 A 
pe 
eee 
d
m
ee
am
ac
al
ecc
ep
xec
am
d 
m
ee
acpe 
al
ecc
epc
ep 
 
 
 
 
 
 
 
 
 
 
 
 
 B 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 3.17: Histological analysis of a pelota mutant embryo and its wild-type or
heterozygous littermate at E8.5. (A) Wild-type embryo. (B) Mutant embryo is small and
disorganised , with a thick mesoderm and thin ectoderm. ep, ectoplacenta; eee,
extraembryonic ectoderm; epc, ectoplacental cavity; ecc, exocoelomic cavity; a, allantois;
am, amnion; pe, parietal endoderm; ac, amniotic cavity; ee, embryonic ectoderm; m,
mesoderm. (d) deciduas. 
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Figure 3.18: Histological analysis of a pelota mutant embryo and its wild-type or
heterozygous littermate at E8.5. (A) Wild-type embryo. (B) Mutant embryo is much
smaller and resorbed. ep, ectoplacenta; epc, ectoplacental cavity; ecc, exocoelomic cavity;
a, allantois; am, amnion; pe, parietal endoderm; ac, amniotic cavity; png, posterior neural
groove; ys, yolk sac; hf, head fold; s, somites. (d) decidua. 
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3.5 Pelota mutation affects proliferation of inner cell mass of blastocysts in vitro 
 
The fact that differentiation of the three germ layers is initiated in the pelota-/- embryos 
suggests that the developmental arrest is not due to lack of differentiation, but rather results 
from a proliferation defect. To directly determine the growth capability of mutant pelota-/- 
embryos, E3.5 blastocysts from heterozygous intercrosses were collected and cultured 
individually in 96 well plates for 7 days. The cultured embryos were photographed each 
day. After 7 days, the DNA of the embryos was extracted and their genotypes were 
determined by PCR assay (Fig. 3.19). After two days in culture, pelota+/+, pelota+/- and 
pelota-/- blastocysts hatched from the zone pellucida, implanted onto the tissue culture 
plastic and form a multi-component structure in which the inner cell mass (ICM) grows  
as mound on top of the extraembryonic (but embryonically derived) trophoblast cells  
(Fig. 3.19 A, B). During the first 4 days in culture, the inner cell mass (ICM) of pelota-/- 
blastocysts was indistinguishable from that of pelota+/+ and pelota+/-. However, while the 
ICM cells of pelota+/+ and pelota+/- embryos continued to expand throughout the 7-day 
culture period, pelota-/- ICM cells failed to expand subsequent to day 4 and the embryos 
invariably died by day 6 in culture (Fig. 3.19 E, F).  In contrast, pelota-/- trophoblast giant 
cells (TGC) remained attached to the culture dish and continued to grow in size through  
7 days of culture. Trophoblast giant cells are derived from cells that became mitotically 
inactive at about E4.5 and undergo repeated rounds of S-phase, generate polyploid nuclei 
and a large cytoplasm (Rough, 1990). Genotyping of cultured embryos was performed by 
PCR reaction (Fig. 3.20). The PCR analysis revealed 5 of 34 cultured embryos as pelota-/- 
(Table 3.1). All blastocysts for which the growth of their inner cell mass was arrested after 
four days of culture were found as pelota-/-.  
The survival of mitotically inactive pelota-/- trophoblast gaint cells and the death of 
mitotically active inner cell mass of pelota-/- blastocysts support our hypothesis that pelota 
is required during mitosis. 
 
3.6 Pelota is required for progress of the mitotic cell cycle 
 
In Drosophila, the mitotic division appears to progress normal in homozygous mutants for 
pelota. In contrast, meiotic cell cycle of spermatogenic cells is arrested during the G2/M 
transition of the first meiotic division. The duplication of DNA content during the S-phase 
and failure of chromosomes to segregate in the arrested cells during M-phase result in 4n 
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germ cells. To demonstrate that the pelota-/- cells of inner cell mass of cultured E6.5 and of 
E7.5 had passed through S-phase, DNA ploidy analysis with CAS imaging system was 
performed. More than 90% of cells dissociated from 6 blastocysts, which are collected 
from heterozygous intercrosses and cultured for 2 days, displayed 2n DNA content, 
whereas 30-40% of analysed cells from 2 embryos exhibited 4n DNA contents (Table 3.4). 
It was difficult to determine the genotype of these cultured cells of blastocysts. 
 To analyse the DNA contents in embryonic cells of E7.5, sections of 8 developmentally 
delayed embryos (mutant) and 10 control embryos were subjected to CAS image analysis 
(Fig. 3.21 A, B). 19-51% of analysed cells in developmental delayed E7.5 displayed 4n 
DNA content, whereas 0-12% of analysed cell in control embryos were polyploid (Table 
3.5). Statistical analysis indicates that the ratio of DNA ploidy of cells in developmentally 
delayed embryos was significantly different from that in control embryo. These data 
suggest that the deficiency of pelota results in a cell cycle arrest at the G2/M transition. 
To support this hypothesis, mitotic spreads were prepared from blastocysts grown for  
2 days in culture and then treated with nocodazole for 6 hr to disrupt spindle microtubules. 
In these experiment, 8-12 metaphases/embryos could be examined in each blastocyst.  
In mitotic spread of two embryos, 3-4 metaphases contained 80 chromosomes (Fig. 3.22 
B), while the rest of examined metaphases contained approximately 40 chromosomes  
(Fig. 3.22 A). In contrast, all examined metaphases in mitotic spread of 11 normal embryos 
contained a diploid number of 40 chromosomes. 
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 Figure 3.19: Growth of wild-type and pelo-/- embryos in culture. E3.5
blastocysts from pelota heterozygous intercrosses were cultured in vitro for
six days and photographed using phase contrast microscopy each day. A, B
blastocysts were cultured for 48 hr (E5.5); C, D, blastocysts were cultured for
4 days (E7.5); E, F, blastocysts were cultured for 6 days (E9.5). Arrows point
to the inner cell mass (ICM) and to the trophoblast giant cells (TGC).
Genotypes were determined by PCR. 
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 Figure 3.20: PCR genotyping of cultured embryos. At E9.5 in culture,
DNA was extracted from individual cultures. PCR reactions were
performed to amplify the wild-type allele (250 bp) and disrupted allele
(216 bp) and the samples were then analysed on ethidium bromide-stained
agarose gel. ``M´´ indicates molecular weight markers. 
 
 
 
 
 
 
 
 
Table 3.4: DNA content in cultured cells of E5.5 recovered from pelota
heterozygous intercrosses.    
 
1  10  20  80  polyploid 
2  10  92  08  diploid 
3  06  85  15  diploid 
4  16  100  00  diploid 
5  03  100  00  diploid 
6  08  99  01  diploid 
7  26  90  10  diploid 
8  05  10  90  polyploid 
Embryo Total number Diploid  Polyploid Ploidy- 
Number  of cells  cells %  cells %  state 
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Figure 3.21: DNA content in cells of embryos at E7.5. The DNA ploidy of cells of
embryos was analysed by Feulgen staining and CAS image analysis. (A) Distribution of
DNA in cells of wild-type blastocysts; (B) Distribution of DNA in cells of a mutant
embryo which contains 30% of tetraploid cells.   
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 Table 3.5: DNA content in cells of embryos at E7.5 recovered from pelota heterozygous
intercrosses. 
 
1  80  80  20  Polyploid Abnormal
2  63  69  31  Polyploid Abnormal
3  49  67  33  Polyploid Abnormal
4  39  49  51  Polyploid Abnormal
5  63  77  23  Polyploid Abnormal
6  45  70  30  Polyploid Abnormal
7  60  57  43  Polyploid Abnormal
8  11  81  19  Polyploid Abnormal
9  49  100  00  Diploid  Normal 
10  44  91  09  Diploid  Normal 
11  31  88  12  Diploid  Normal 
12  80  96  04  Diploid  Normal 
13  71  97  03  Diploid  Normal 
14  103  100  00  Diploid  Normal 
15  25  99  01  Diploid  Normal 
16  76  98  02  Diploid  Normal 
17  35  91  09  Diploid  Normal 
18  4  96  04  Diploid  Normal 
Embryo Total number Diploid  Polyploid Ploidy-  Phenotype 
number of cells cells % cells % state  of embryo. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Results 70
 
 
 
 
 
 
 
 
 
 
BA  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.22: Metaphase spreads of cells derived from blastocysts cultured for two
days. (A) diploid cell; (B) tetraploid cell. Magnification x650. 
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3.7 Pelota protein is associated with the centrosome 
 
The high rate of polyploidy seen in cells of the pelota deficient E7.5 suggests that loss of 
pelota protein leads to disruption either in kinetochore assembly structure, in centrosome 
or in microtuble formation. These cellular structures are involved in chromosome 
segregation. To address this question, subcellular localization of pelota protein was 
determined by establishing stable transfected ES-clones that constitutively express green 
fluorescent protein (GFP)-targeted pelota. 
 
3.7.1 Construction of a GFP-pelota plasmid 
 
To construct a green fluorescence/pelota (GFP-pelota) expressing plasmid, a fragment 
containing the cDNA nucleotide sequence with an artificial XhoI site at 5’ end and a SmaI 
site at the 3’ end was amplified by PCR using the human pelota cDNA as template. The 
amplified fragment was double digested with XhoI and SmaI and subcloned into the 
plasmid pEGFP-C1 to produce pGFP-pelo (Fig. 3.23). The nucleotide sequence of this 
construct was confirmed by sequencing.  
 
 3.7.1.1 Transfection of 3T3 fibroblast cell with the pGFP-pelo and subcellular 
localisation of the GFP-fluorescence signal in transfected cells 
 
The 3T3 fibroblast cells grown on glass slides were transfected with 2µg of the pGFP-pelo 
plasmid as described in (2.2.20.1). The cells were fixed with methanol and examined by 
Olympus BX60 microscope. The microscopic examination of the transiently transfected 
3T3 cells revealed that the green fluorescent protein (GFP)-targeted pelota is distributed in 
the cytoplasm (Fig. 3.24). The examination of the nuclear morphology in transfected cells 
by DAPI counterstaining revealed that all of these cells were in interphase. 
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Figure 3.23: Strategy to subclone the pelota-cDNA in the pEGFP-C1 vector. (A) The
human pelota cDNA fragment was amplified using the primer pECFP-C1F, which
contains the sequence of the restriction site XhoI at the 3’ end and the primer pECFP-C1R
containg the sequence of the restriction site SmaI at the 5’ end. The 980 bp amplified
product was digested with the XhoI/SmaI and subcloned into XhoI/SmaI digested pEGFP-
C1 vector. (B) Structure of the pEGFP-C1 vector. (C) GFP-pelota-fusion construct. Xh,
XhoI ; Sm, SmaI, ATG, start codon ; TAA, stop codon, CMV, Human cytomegalovirus
promoter; Neo, Neomycin resistance gene. 
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 Figure 3.24: Transfection of fibroblast cells with GFP-pelota-fusion construct. (A)
DAPI staining of nuclei of transfected fibroblast cells (all the nuclei show blue
colour). (B) GFP-pelota-fusion protein located in the cytoplasm of fibroblast cells.
5% of cells were transfected (green colour from GFP gene). (C) Overlay-images of
DAPI staining for the nucleus and GFP-pelota in the cytoplasm in only 5% of the
cells.    
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3.7.1.2 Transfection of the ES cells with the pGFP-pelota and selection of stable 
transfected ES cells 
 
To avoid potential abnormal localisation of GFP-pelota fluorescence signal due to over- 
expression of the GFP-pelota fusion protein in the transiently transfected cells, embryonic 
stem cells were transfected with the ApaLI linearized pGFP-pelota construct by 
elecroporation. GFP-pelota expressing clones were initially isolated by G418-resistance 
selection. Of these clones, those were selected for the expression of the GFP-pelota fusion 
gene that yield a sufficient GFP-fluorescence signal. Three of these clones appeared to be 
stable after 10 passages in the absence of G418. This strategy enabled us to study the 
subcellular localization of GFP-pelota fusion protein during the cell cycle. Microscopical 
examination of the transfected ES cells showed that GFP-fluorescence is localised in  
a single dot directly adjacent to the nucleus of the prophase (Fig. 3.26 B). In metaphase, 
the GFP-fluorescence signal was decorated at both poles of the cell (Fig. 3.28 B). This 
pattern of localization of the GFP-fluorescence signal in the GFP-pelota transfected cells 
suggests that the GFP-pelota fusion protein is associated with the centrosome. The GFP-
pelota fusion protein was not only localised at centrosomes, but was also distributed 
uniformly over the cytosol (Fig. 3.28 B). To confirm the localization of the GFP-pelota at 
centrosomes, immunostaining of the GFP-pelota transfected ES cells with monoclonal anti 
γ-tubulin was performed. As shown in figures 3. 25, 3. 26, 3. 27 and 3.28 the γ-tubulin 
could be co-localized exactly with the GFP-fluorescence signal in interphase, prophase and 
metaphase. These results indicate that the pelota protein is associated with the 
centrosomes. 
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Figure 3.25: Immunofluorescent localization of GFP-pelota protein in transfected ES
cells. Interphase cells showing GFP-pelota (green), γ-tubulin (red), and DNA (blue). (A)
Localization of GFP-Pelota proteins in the centrosome (B) Immunfluorescent staining of GFP-
pelota-recombinant ES cells with anti-γ-tubulin. (C) The co-localization of γ-tubulin-staining with
green fluorescent GFP-Pelota-signal. (D) Overlay-images of GFP-pelota protein for centrosome
and DAPI-Staining. (E) Overlay images of γ-tubulin and DAPI-staining. Arrows indicate
centrosomes.  
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Figure 3.26: : Immunofluorescent localization of GFP-pelota protein in transfected ES cells.
Prophase cells show the two centrosomes adjacent to the nucleus. (A) Immunofluorescent staining of
GFP-pelota-recombinant ES cells with anti-γ -tubulin (red). (B) Localization of GFP-pelota proteins in
the centrosome. (C) DAPI-staining for DNA. Arrows indicate centrosomes. 
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 Figure 3.27: Transfection of ES cells with GFP-pelota-fusion construct. Prophase cells show
the two centrosomes (A) Immunfluorescent staining for GFP-pelota-recombinant ES cells with
anti-γ-tubulin (red). (B) Overlay images of green fluorescent of GFP-pelota protein in
centrosome and DAPI-staining for DNA (blue). (C) Overlay images of anti-γ-tubulin and DAPI-
staining. (D) The co-localization of γ-tubulin-staining with GFP-pelota-signal. Arrows indicate
centrosomes. 
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Figure 3.28: GFP-pelota-recombinant ES cells in metaphase and interphase stages. (A)
Immunofluorescent staining with anti-γ-tubulin (red). (B) Localization of GFP-pelota proteins in the
centrosome (green). (C) DAPI-staining for chromosomes (blue). (D) Overlay-images of γ-tubulin
and DAPI-staining. (E) Overlay-images of GFP-pelota protein and DAPI-staining. (F) The co-
localization of γ-tubulin-staining with GFP-pelota-signal. Short and long arrows indicate
centrosomes in metaphase and interphase stages, respectively.  
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4. DISCUSSION 
 
4.1 Pelota is highly conserved during evolution 
 
The pelota gene has been isolated and characterized in Archaebacteria Methanococcus 
jannaschii (Bult et al., 1996), Sulfolobus solfataricus (Ragan et al., 1996), in yeast 
Saccharomyces cerevisiae (Davis and Engebrecht, 1998), in worm Caenorhabditis elegans 
(Gen Bank, Accession No. Z36238), in plant Arabidopsis thaliana (Gen Bank, Accession 
No. T20628), in human (Shamsadin et al., 2000) and in mouse (this work). Comparison of 
the predicted amino acid sequence of pelota from the seven species reveals a high level of 
sequence conservation (Fig. 4.1). The sequence identity ranges from 31% between mouse 
and S. cerevisiae and 95% between mouse and human (Table 4.1). Considering 
conservative changes of the amino acid, the overall similarity between mouse and human 
reaches to 98.5%. The seven predicted proteins have start and stop codons in similar 
locations, with the exception of a small extension in N-terminal of S. cerevisiae predicted 
protein. Homology between the proteins was distributed across the entire protein.  
 
The PROSITE protein motif library failed to reveal major structural motifs indicating  
a particular biological function for the pelota protein. However, numerous putative 
phosphorylation motifs were detected, spread across the length of the predicted protein, in 
the mammalian sequence. This includes motifs for protein kinase C, casein kinase II and 
tyrosine kinase phosphorylation sites. Furthermore, two N-glycosylation and three  
N-myristoylation sites were detected in the mammalian proteins. It is currently unknown 
which of these putative motifs are physiologically significant for posttranslational 
modifications. Davis and Engebrecht (1998) reported that the pelota of S. cerevisiae 
contains three regions that display similarity to conserved motifs: (1) A putative nuclear 
localization signal (NLS) is located at residues 173-177 of the yeast protein. This sequence 
PKKKR is similar to PKKKRK of simian virus 40 (SV40) large T antigen. (2) Residues 
267-323 are highly similar to a protein of eukaryotic peptide chain release factor subunit I 
(ERFI). The ERFI family of protein is involved in the termination step of protein synthesis 
(Frolova et al., 1994). (3) A putative leucine zipper motif is located at the C-terminus of  
S. cerevisiae protein. Leucine zippers have been suggested to mediate protein-protein 
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interactions in a diverse set of functionally unrelated proteins (Busch and Sassone-Corsi, 
1990). Alignment of seven proteins (Fig. 4.1) revealed that the other pelota proteins share 
the NLS, ERFI and leucine zipper motifs.  
 
The localization of the GFP-fluorescent signal in the centrosome of the GFP-pelota 
transfected ES-cells as well as localization of the GFP-fluorescence only in cytosol of the 
GFP-pelota transfected 3T3 cells rule out that the nuclear localization signal of the pelota 
protein is functionally relevant. All pelota proteins contain 2-4 leucine zipper motifs. 
Therefore, it is important to address, whether the leucine zipper motifs are involved in 
dimerization of the pelota with other proteins and to identify the protein partners of pelota. 
This question can be addressed using the method of yeast two hybrid system.  
A phylogenetic analysis of pelota primary amino acid sequences from different species 
using the distance matrix program, CLUSTALW (Higgins et al., 1992) is shown in figure 
4.2. The degree of sequence similarity is entirely congruent with the evolutionary 
relationship of the respective organisms. This is in support of the idea that the pelota genes 
are all derived from the same ancestral gene.   
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 Mouse               --MKLVRKDIEKDNAGQVTLVPEEPEDMWHTYNLVQVGDSLRASTIRKVQTESSTGSVGS 58 
Human               --MKLVRKNIEKDNAGQVTLVPEEPEDMWHTYNLVQVGDSLRASTIRKVQTESSTGSVGS 58 
Drosophila          --MKLLGKYVDKGMQGNVTLVPEESEDMWHAYNLIAKGDSVRSTTIRKVQNFTATGSSTS 58 
C.elegans           --MKQFKRGIERDGTGFVVLMAEEAEDMWHIYNLIRIGDIIKASTIRKVVSETSTGTTSS 58 
A.thaliana          --MKIVRRDFVRNGPGSVKMVAEDSDDLWYAYNLIAVGDSVMAVTFRKVQREIPGGGRDS 58 
S.cerevisiae        MKVISLKKDSFNKGGAVITLLPEDKEDLFTVYQIVDKDD--ELIFKKKFTSKLDEAGKKK 58 
Archaebacteria      --MKIIEEIPQKN---IIKLMPENLDDLWVLYNIIEEGDKIFAVTERRVQDKGDVIRADR 55 
CONSENSUS:             KLVRK IEK   G VTLVPEE EDMWH YNLI VGDSLRASTIRKVQTES TGS  S 
                        ILK  VD                         I   IK T      S T   T    
 
Mouse               -NRVRTTLTLCVEAIDFDSQACQLRVKGTNIQE-----KEYVKMGAYHTIELEPNRQFTL 112
Human               -NRVRTTLTLCVEAIDFDSQACQLRVKGTNIQE-----NEYVKMGAYHTIELEPNRQFTL 112
Drosophila          -SFVRTTLTIAVESIDFDTQACVVRLKGRNIEE-----NQYVKMGAYHTLDLELNRKF L 112E
C.elegans           -QRVHTMLTVSVESIDFDPGAQELHLKGRNIEE-----NDIVKLGAYHTIDLEPNRKFTL 112
A.thaliana          -ERVKLKLEVQVEEVDYDKDGSVLRIRGKNILE-----NEHVKIGAFHTLELELKRPF L 112V
S.cerevisiae        -STDLVKLKIKVIS DFDMKDEYLK KGVTVTDESGASNVDIPVGKYLS LDYVYPFTI 117E Y FT
Archaebacteria      GAKRKMFLGIEVKNVEFDENTKRVRILGTIIHG-----PDDVPLGSHHTIEIKPFDELSI 110
CONSENSUS:            RVRT LTL VE IDFD QA  LRVKG NI E     NE VKMGAYHTIELEPNR FTL 
                        K    I         N     L             D   L                 
 
Mouse               AKKQWDSVVLERFEQACDPAWSADVAAVVMQEGLAHVCLVTPSMTLTRAKVEVNIPRK-R 171
Human               AKKQWDSVVLERIEQACDPAWSDDVAAVVMQEGLAHICLVTPSMTLTRAKVEVNIPRK-R 171
Drosophila          RKPEWDTIALERIEMACDPTQSADVAAVVMQEGLAHVCLITASMTLVRSKIVESIPRK-R 171
C.elegans           QKTEWDSIDLERLNLALDPAQAADVAAVVLHEGLANVCLITPAMTLTRAKIDMTIPRK-R 171
A.thaliana          RKEMWDSMALDTLKQASDPAASADLAVVLMQEGLAQIFLVGRSVTSSRARIETSIPRK-H 171
S.cerevisiae        IKQNFNKFMQKLLNEACNIEYKSDTAAVVLQEGIAHVCLVTSSSTILKQKIEYSMPKKKR 177
Archaebacteria      EKN-WKKWQIERIKEAIESSKRPKVLVVVMDDEEADIFEVRDYSIKEICSIKSHTSKK-- 167
CONSENSUS:           K  WDSV LERI  ACDPA SADVAAVVMQEGLAHVCLVT SMTLTRAKVE SIPRK R 
                           I    L                                 S   I  T       
 
Mouse               KGNCSQHDPALERFYEQVVQAIQRHINFEVVKCVLVASPGFVREQFCDYMFQQAVKTDNK 231
Human               KGNCSQHDRALERFYEQVVQAIQRHIHFDVVKCILVASPGFVREQFCDYMFQQAVKTDNK 231
Drosophila          KGSVQQHEKGLAKFYEQVMQSILRHVDFDVVKCVLIASPGFVRDQFYDYMFQQAVKMDYK 231
C.elegans           KGFTSQHEKGLEKFYEAVSTAFMRHVNLQVVKCVIVASRGFVKDAFMQHLIAHADANGKK 231
A.thaliana          GPAIAGYESALKKFFENVLQAFVKHVDFSVVRCAVVASPGFTKDQFHRHLLLEAERRQLR 231
S.cerevisiae        TTDVLKFDEKTEKFYKAIYSAMKKDLNFDKLKTIILCSPGFYAKILMDKIFQYAEEEHNK 237
Archaebacteria      -----LDYKINEELKKEYYHEIAKVLSEYDVDNILVAGPGFAKNSFYNFISSQYPELKNK 222
CONSENSUS:          KG   QHD ALEKFYEQVVQAI RHV FDVVKCVLVASPGFVRDQF D MFQQA K  NK 
                           E G      N M      L  E    I        KE     L     R 
 
Mouse               VLLENRSKFL-VHASSGHKYSLKEALCDPTVASRLSHTKAAGEVKALDDFYKMLQHEPDR 290
Human               LLLENRSKFL VHASSGHKYSLKE LCDPTVASRLSDTKAAGEVKALDDFYKMLQHEPDR 291Q A
Drosophila          LLLDNKSKFMLVHASSGFKHSLREILQDPAVLAKMSDTKAAGEVKALEQFYMMLQCEPAK 291
C.elegans           F EQRAKFMLTHSSSGFKHALKEVLETPQVALRLADTKAQGEVKALNQFLELMSTEPDR 291TT
A.thaliana          PIIENKSR ILVHTNSGYRHSLGEVLHAPNVMN IKDTKAAKEVKAL DFHNML TEPDR 291I M N S
S.cerevisiae        KILDNKGMFFIAHCSTGYLQGINEVLKNPLYASKLQDTKYSKEIMVMDEFLLHLNKDDDK 297
Archaebacteria      IVVES--------ISTTSRAGLNEVIKRGIINRIYAESRVAKETQLIEKLLEEIAKKG-L 273
CONSENSUS:          LLLENRSKFLLVH SSG K SLKEVL  P VA RL DTKAAGEVKALDDF  MLQ EPDR 
                    VVV  K   MI           R          K             E      N      
 
Mouse               AFYGLKQVERANEALAIDTLLISDELFRHQDVATRSRYVRLVDSVKENAGTVRIFSSLHV 350
Human               AFYGLKQVEKANEAMAIDTLLISDELFRHQDVATRSRYVRLVDSVKENAGTVRIFSSLHV 351
Drosophila          AFYGKKHVLQAAECQAIETLLISDNLFRCQDVSLRQEYVNLVESIRDAGGEVKIFSSMHI 351
C.elegans           AFYGFNHVNRANQELAIETLLV DSLFRAQDIETRRKYVRLVESVREQ GKVHIFSSMHV 351A N
A.thaliana          ACYGPKHVEVANERMAIQTLLITDELFRNSDVKTRKKYV LVESVKD GGDAFIFS MHV 351N S A
S.cerevisiae        AWYGEKEVVKAAEYGAISYLLLTDKVLHSD IAQREEYLKLMDSVE NGGKALVLSTLHS 357N S
Archaebacteria      AVYGIDEVKKALEYSAIDTLLVSDSLVRNHEIEK------IIDTTEEMGGKVVIVSSEHD 327
CONSENSUS:          AFYG K V RANE LAIDTLLISD LFR QDV TR RYVRLVDSVKENGG VRIFSSMHV 
                             K    M  E   V              K  K     RDQ    K    L I 
 
Mouse               SGEQLGQLTGVAAILRFPVPELS--------------------- 372 
Human               YGEQLSQLTGVAAILRFPVPELSDQEGDSSSEED---------- 385 
Drosophila          SGEQLAQLTGIAALLRFPMPELEDSDDDDDEDGAAGGAADSDSD 395 
C.elegans           SGEQLAQLTGCAAILRFPMPDLDDEPMDEN-------------- 381 
A.thaliana          SGEQLAQLTGIAALLRFPLPELEDIEM----------------- 378 
S.cerevisiae        LGEELDQLTGIACILKYPLPDLDEDDGEE--------------- 386 
Archaebacteria      AGKQLKALGGIAGLLRFPIE------------------------ 347 
CONSENSUS:          SGEQLAQLTGIAAILRFPVPELED E D 
                         G       L KY M   D  D E 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 4.1: Alignment of the predicted amino acid sequence of mouse pelota
with related sequences from other species. Numbers represent the amino acid
number in the sequence. Hyphens indicate gaps introduced into the sequence to
maximize alignment. Consensus indicates at least four amino acids with
identical or similar residues at given position. Conserved residues are shown in
boldface type. Conservative amino acids are grouped as follows: S, T; A, G; D,
E; N, Q; H, R, K; I, L, V, M; F, W, Y, C; P.  
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 Table 4.1: Identity (%) of the alignment of amino acid sequences of pelota from several 
species.  
 
A.thaliana
S.cerevisiae 
Drosophila
C.elegans
M.jannaschii
Human
Mouse 
95     65             31    51          59  27 
     64             31    51          57                 28 
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       28          29  24 
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Figure 4.2: Phylogenetic tree of pelota for mouse, human, Drosophila,
S .cerevisiae, Archaebacteria M.jannaschii, A.thaliana and C.elegans. The tree was
constructed using the sequence data of the pelota listed in Figure 4.1. 
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4.2 Expression of the pelota gene during prenatal development and in different mouse 
tissues 
 
To obtain possible clue to pelota function, expression of the pelota gene was examined in 
embryos at different fetal stages and in different tissues of adult mouse. RT PCR analysis 
revealed that the pelota gene is expressed during prenatal development of mice (Fig. 3.2).  
A 1.6 kb pelota mRNA species was easily detected in all examined tissues (Fig. 3.1), 
indicating the constitutive expression of the pelota gene. Unlike the other tissues, a clear 
larger mRNA transcript (2.1 kb) was found in spleen (Fig. 3.1). In human the 2.1 kb pelota 
transcript was only detected in testis (Shamsadin et al., 2000). The length of the 
constitutive transcript is in good agreement with the length of mouse and human pelota 
cDNA (1.6 kb). The origin and significance of the 2.1 kb transcript detected in human 
testis and in mouse spleen remain to be determined. Analysis of expression of the pelota 
gene in Drosophila reveal that the transcript is 2.1 kb in length and is present in all 
developmental stages examined, but was most abundant in 0-2 hr old embryos and in 
adults (Eberhart and Wasserman, 1995). The 2.1 kb transcript was detected in the 
germlineless progeny of oskar mutant flies and in iab mutant flies that lack a gonad. These 
results demonstrate that the pelota transcript is not restricted to the germline or gonad. 
Similar results were also found in mouse. The pelota transcript was detected in the testis of 
W/WV mutant mice, which lack germ cells (Fig. 3.5).   
 
4.3 Mutation of the mammalian pelota gene results in early embryonic lethality 
 
The control of progression through the cell cycle in animal cells is complex with multiple 
control points that may vary depending on the lineage and developmental stage of cell 
(Kuerbitz et al., 1992; Sandell et al., 1993; Hardwick 1998; Chen et al., 1998; Taylor et al., 
1998). Genes controlling cell cycle are generally conserved from human to yeast, including 
the human ATM, Chk1, Mad2 and pelota genes (Xu and Baltimore, 1996; Takai, et al., 
2000; Doles, et al., 2000; Shamsadin, et al., 2000). Multiple mammalian homologues of the 
yeast cell cycle regulation genes have been found, each of which may function at specific 
stages of the cell cycle (review in Pines, 1993). However, the role of particular cell cycle 
genes may vary among species. For example, while the mutation in the pelota gene in 
Drosophila causes an arrest of cell cycle at the G2/M transition of the first meiotic division 
(Eberhart and Wassermann, 1995), mutation in the pelota homologue dom34 in  
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S. cerevisiae shows that progression through the G1 phase of the cell cycle is delayed. 
Mutant cells enter meiosis aberrantly and their ability to form pseudohyphae is 
significantly diminished (Davis and Engebrecht, 1998). 
In order to identify the role of the mammalian pelota gene, we have inactivated the pelota 
gene in mouse genome by replacing exon 2 and 3 by the bacterial neomycin gene (Fig. 
3.9). Chimeric mice were successfully produced and transmitted the mutant allele to their 
progeny. Heterozygous pelota mice (F1) were viable and fertile and show no apparent 
abnormalities in development or fertility. These observation indicates that one functional 
copy of the pelota gene is sufficient for normal development. However, when the 
heterozygous mice were intercrossed, no pelota homozygous mice could be found among 
240 offspring, indicating that pelota deficiency results in embryonic lethality. To 
determine when pelota-/- embryo die, we analyzed embryos from heterozygous intercrosses 
at various points of gestation. At E8.5 – E12.5, none of examined embryos were pelota-/-. 
At E2.5 and E3.5, pelota-/- was detected in an expected ratio for a Mendelian distribution 
suggesting that pelota-/- embryos die between E3.5 and E8.5.  
A normal mouse blastocyst attaches to the uterus between E4.5 and E5.0 (Rinkenberger,  
et al., 1997). Even embryos that die or are degraded shortly after attachment stimulate 
decidualization, a process whereby stromal cells expand, elaborate extracellular matrix and 
form tight junctions (Welsh, 1993). Histological sections of deciduas at E6.5 – E8.5 
revealed no evidence of embryo resorption or empty deciduas at E6.5. All histological 
examined at E6.5 appeared to be normal. Examinations at E7.5, two phenotypes were 
obvious, one normal and one other abnormal. Smaller, poorly organized abnormal embryos 
could be readily distinguished among their wild-type littermates (Fig. 3.16). These results 
indicate that the pelota mutation affects the embryonic development before E7.5. At E8.5, 
phenotypic differences became even more apparent. The fact that differentiation of the 
three germ layers is initiated in the pelota-/- embryos suggests that the developmental arrest 
is not due to lack of differentiation, but rather results from a proliferation defect. 
Expression analysis showed that the pelota gene is ubiquitously expressed throughout 
development, including embryonic stem cells. However, no defects were observed in the 
preimplantation pelota-/- embryos, suggesting that any pelota function at this stage is 
compensated for either by maternally encoded pelota or by other proteins that have similar 
function. The pelota-/- embryos implant normally and stimulate a decidual reaction. This 
consistent with the observation that the embryonic cells spread and attach normally in the 
first few days of blastocyst culture (Fig. 3.19). 
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4.4 Mutation of the pelota gene arrests the mitotic division at G2/M boundary 
  
 In uterus, pelota null embryos die after the initiation of gastrulation (E6.5),  
a particularly active period of cell division characterized by very short cell cycle (as short 
as 2 hr) (Snow, 1977; Hogan et al., 1994). To determine cellular proliferation and viability 
at the early embryonic development, blastocysts were isolated from heterozygous 
intercrosses. Blastocysts are composed of two cell types, pluripotent cells in the inner cell 
mass and trophectoderm cells (review in Hogan et al., 1994; Kaufman, 1992). When 
control blastocysts were grown in tissue culture, cells derived from the inner cell mass 
(ICM) became highly proliferative and cells derived from the trophectoderm (trophoblast - 
like cells) became relatively quiescent. In culture, while the ICM cells of pelota+/+ and 
pelota+/- embryos continued to expand throughout the 7-day culture period, pelota-/- ICM 
cells failed to expand subsequent to day 4 and the embryo invariably died by day 6 in 
culture. In contrast, pelota-/- trophoblast cells continued to grow in size through 7 days of 
culture. These results demonstrate that the death of pelota-/- cells is restricted to the rapidly 
dividing cells of the ICM. The survival of mitotically inactive pelota-/- trophoblast cells 
further argues that pelota is required selectively in cells undergoing mitosis. In addition, 
numerous attempts to generate pelota homozygous mutant ES cells were done by 
increasing G418 concentration. These approaches were unsuccessful.  
 
These results from in vitro experiments directly support a generalized failure in cellular 
proliferation in pelota mutant. Survival of the pelota-/-  embryos until E6.5 rises the 
question, why does the failure in cellular proliferation only become apparent so late in 
development. One possibility is that in mice, as in Xenopus, the checkpoint does not 
function (is not required) in the very early embryonic cell cycles (Chen et al., 1996). A 
second possibility is that maternal transcripts provide sufficient pelota for early division, 
but the maternal store is eventually exhausted. However, several studies have shown that 
the vast majority of RNA in E3.5 and later embryos arises from zygotic transcription and 
that maternal mRNA is largely gone (Bachvarova and Deleon, 1980; Nothias et al., 1995). 
Exhaustion of maternal pelota mRNA therefore seems an unlikely explanation for the late 
onset of a phenotype. A final possibility is that the requirement of pelota only becomes 
critical at about the time of gastrulation, when embryos enter a period of rapid cell division 
(E6.5). The final possibility may explain the arrest of cell proliferation in postimplantation 
stage of pelota mutant embryos.  
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Postimplantation lethality and failure of ICM cells to proliferate in culture were reported 
for knockout mice, which lack genes controlling the mitotic cell cycle. However, the cause 
of proliferation arrest varied among these different mutant mice. Lacking of the checkpoint 
protein Mad2 results in chromosome missegregation (Dobles et al., 2000). Extensive 
chromosomal fragmentation was observed in the ATR deficient cells (Brown and 
Battimore, 2000). Disruption of many genes involved in double-stranded break repair, 
including BRCA1, BRCA2, RAD50, RAD51 and MRE11, lead to early embryonic lethality 
in mice. Many of these genes have also been shown to be essential for ES cell viability and 
chromosomal stability (Hakem et al., 1996; Lim and Hasty, 1996; Sharan et al., 1997; Luo 
et al., 1999; Yamaguchi-Iwai et al., 1999). 
To identify the cause of proliferative arrest in the pelota-/- embryo, DNA content in 
embryonic cells of E7.5 was determined by CAS image analysis. This analysis indicate 
that 19 - 51% of analyzed cells in E7.5 displayed 4n DNA content whereas 0 - 12% of 
analyzed cells in control embryos were found to be polyploid. These data suggest that the 
deficiency in pelota embryos results in cell cycle arrest at the G2/M transition. 
 
The lethal phenotype observed in the pelota mutant embryos was unexpected because in 
Drosophila mitotically dividing cells deficient for pelota are viable. There are two possible 
explanations for this discrepancy. One is that mammalian pelota maintained the same 
function as Drosophila pelota, but this function is essential in mammalian cells but not in 
Drosophila. Another possibility is that the pelota Drosophila mutant is not a null allele. 
The mutation in Drosophila resulted from insertion of P element in the second intron of the 
gene (Eberhart and Wasserman, 1995). 
 
4.5 Pelota is localized in the centrosomes 
  
Subcellular localization of the pelota protein was determined by immunofluorescence 
microscopy of GFP-pelota transfected ES cells. GFP-fluorescence signals were found to 
localize to centrosomes throughout the cell cycle in ES cells, as judged by colocalization 
with the γ-tubulin (Fig. 3.35; 3.36; 3.36; 3.37 and 3.38). These data suggest that the pelota 
is associated with centrosomes during the cell cycle. 
 
Centrosomes in normal mitotic cells facilitate the assembly of bipolar spindle and assure 
equal distribution of the replicated genome to each daughter cell. Moreover, this process 
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provides each daughter cell with a single centrosome. The regulatory mechanism 
(checkpoint) that assures that centrosomes divide only once in a given cell cycle 
establishes a condition favouring a bipolar spindle assembly and mitotic stability. 
Presumably, mutations or altered expression of genes controlling centrosome duplication 
could abrogate the checkpoint that assures a single round of centrosome replication, 
resulting in cells that assemble more than the usual pair of centrosomes. Mutational 
inactivation of the tumor suppressor gene BRCA 1 (Xu et al., 1999) and P53 (Fukasawa et 
al., 1996), which are also associated with the centrosomes, was reported to alter a 
checkpoint and initiate multiple round of centrosome replication within a single cell cycle. 
Isolated fibroblasts from these mutant mice contain multiple centrosomes, which lead to 
unequal chromosome segregation and aneuploidy. More recently, supernumerary 
centrosomes have been reported in a variety of different tumor cells in vitro and in vivo 
(Lingle et al., 1998; Pihan et al., 1998; Ghadimi et al., 2000). During the meiotic division 
in Drosophila pelota mutant, spindle apparatus is not formed. Therefore, it is very 
important to address the question, whether the inactivation or overexpression of pelota 
gene affects the centrosome duplication. This can be addressed by establishment of  
pelota-/- cell lines from conditional knockout mice and from transgenic mice 
overexpressing pelota gene or from generated stabile transfected cell lines that express the 
antisense pelota-transcript. 
 
Centrosome contains a pair of centrioles surrounded by an electron-dense pericentriolar 
matrix, from which a polarized array of cytoplasmic microtubules is assembled. Cells 
lacking centrioles can still form bipolar spindles (review in Marshall, 2001). Recent reports 
reveal that the centrioles regulate the orientation of the bipolar spindle in the dividing cells. 
In the unicellular green alga Chlamydomonas, mutant bald2 has severe defects in centriole 
structure. Analysis of cell division in bald2 mutant strains in which spindle assembly and 
mitosis proceed normally, the spindle was often misorientated with respect to the cleavage 
furrow, resulting in cytokinesis errors (Goodenough and StClair, 1975; Ehler et al., 1995). 
Drosophila mutant lacking centriole–associated protein fail to develop and show dramatic 
defect in cell division (Vaizel-Ohayon and Schejter, 1999; Megraw et al., 2001). Mouse 
embryo cells complete up to 16 cell divisions without centrioles and then generate new 
centrioles de novo in subsequent cell divisions (Szollosi, 1972; Calarco, 2000). If the 
pelota is one of structural proteins in the centrioles, one can speculate that the lack of 
pelota affects the centriole formation in embryonic cells and mediates the arrest of mitotic 
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division. This can explain why the mitotic divisions is only affected after E7.5 in pelota 
deficient embryos. 
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5 SUMMARY 
 
Expression and function of the pelota gene has originally been characterized in 
Drosophila. A loss-of-function mutation in Drosophila pelota was found to result in male 
infertility. Spermatogonia and spermatocytes are produced in mutant flies but the cell cycle 
of the first meiotic division is arrested during the G2/M transition.  
 
In the present work, the expression pattern and physiological function of the mouse pelota 
gene was studied. 
The expression of the pelota gene in different mouse tissues was analysed by Northern 
blot. A 1.6 kb pelota transcript was detected in the RNA of all studied tissues. An 
additional 2.1 kb pelota transcript was observed in RNA of the spleen. To investigate the 
expression of the pelota gene during prenatal development, RNA was extracted from the 
posterior part of 9.5 to 17.5 dpc. embryos and analysed for the presence of pelota transcript 
by RT-PCR. Pelota transcripts were detected in all studied embryos. To evaluate the 
expression of the pelota gene during testicular development, Northern blot with RNA 
extracted from testes of 5- to 60 –day old mice was performed. The results of Northern blot 
hybridisation revealed that the pelota gene is expressed throughout postnatal testis 
development. Further Northern blot analyses with testicular RNA isolated from mutant 
mice indicate that the expression of the pelota gene is not restricted to spermatogenic cells 
of the testis. 
To elucidate the potential role of the mammalian pelota gene, the gene was deleted in mice 
through homologous recombination. Both male and female mice heterozygous for pelota 
deletion were phenotypically normal and fertile. Heterozygous animals were intercrossed 
and the offspring were genotyped by PCR analysis. No pelota-/- animals were detected in 
the F2 generation. These results indicate that pelota deficiency results in embryonic death. 
To assess the consequence of the pelota mutation for embryonic development, embryos 
were collected from heterozygous intercrosses at different days of prenatal development. 
PCR analysis of postimplantation embryos dissected from the deciduas at embryonic days 
(E) 8.5, 9.5 and 10.5 showed that none of studied embryos was pelota-/-, while analysis of 
preimplantation embryos at E2.5 and 3.5 revealed the presence of pelota-/- embryos in the 
expected ratio as defined by Mendelian distribution. These results demonstrate that pelota-
/- embryos die between E3.5 and E8.5.  
5 Summary 90
To determine the cause and time of embryonic lethality, histological analysis of deciduas at 
embryonic days 6.5, 7.5, 8.5 and 9.5 were performed. The results of these studies revealed 
that the development of the pelota deficient embryos up to E6.5 appears normal but slows 
down at the E7.5. After E9.5, no viable pelota-/- were observed. The fact that 
differentiation of the three germ layers is initiated in the pelota-/- embryos suggests that the 
developmental arrest is not due to lack of differentiation, but rather results from  
a proliferation defect. To directly determine the growth capability of mutant pelota-/- 
embryos, E3.5 blastocyts from heterozygous intercrosses were collected and cultured 
individually for 7 days and then genotyped by PCR. During the first 4 days in culture, the 
inner cell mass (ICM) of pelota-/- blastocysts was indistinguishable from that of pelota+/+ 
and pelota+/-. However, while the ICM cells of pelota+/+ and pelota+/- embryos continued 
to expand throughout the 7-day, pelota-/- ICM cells failed to expand subsequent to day 4. In 
contrast, pelota-/- trophoblast gaint cells (TGC) continued to grow in size through 7 days of 
culture. The survival of mitotically inactive pelota-/- trophoblast gaint cells and the death of 
mitotically active inner cell mass of pelota-/- blastocysts support our hypothesis that pelota 
is required during mitosis. 
To address the question whether the mitotic cell cycle is arrested in the pelota-/- embryos, 
DNA contents in embryonic cells of E7.5 was determined with CAS image system. Results 
of these studies suggest that the deficiency of pelota results in a cell cycle arrest at the 
G2/M transition. 
To determine the subcellular localization of pelota protein, embryonic stem cells (ES) were 
transfected with green fluorescent protein (GFP)-targeted pelota and expressing clones 
were selected. Microscopic examination of the transfected ES cells showed that GFP-
fluorescence signal was localized at the centrosomes. Immunostaining of the GFP-pelota 
transfected ES cells with monoclonal anti γ-tubulin demonstrated that the γ-tubulin, a 
marker for centrosomes, colocalized exactly with the GFP-fluorescence signal in 
interphase, prophase and metaphase. These results indicate that pelota protein is associated 
with the centrosome. 
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